REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 |
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Title of each class |
Trading Symbol |
Name of each exchange on which registered | ||
/A |
* | Not for trading, but only in connection with the listing of the American depositary shares on the New York Stock Exchange. |
Large Accelerated Filer | ☐ | Accelerated Filer | ☐ | ☒ | ||||||
Emerging growth company |
† | The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012. |
☒ |
☐ | International Financial Reporting Standards as issued by the International Accounting Standards Board |
☐ | Other |
Page |
||||||
1 |
||||||
3 |
||||||
4 |
||||||
ITEM 1. |
4 |
|||||
ITEM 2. |
4 |
|||||
ITEM 3. |
4 |
|||||
ITEM 4. |
54 |
|||||
ITEM 4A. |
98 |
|||||
ITEM 5. |
98 |
|||||
ITEM 6. |
114 |
|||||
ITEM 7. |
122 |
|||||
ITEM 8. |
126 |
|||||
ITEM 9. |
127 |
|||||
ITEM 10. |
128 |
|||||
ITEM 11. |
136 |
|||||
ITEM 12. |
137 |
|||||
139 |
||||||
ITEM 13. |
139 |
|||||
ITEM 14. |
139 |
|||||
ITEM 15. |
139 |
|||||
ITEM 16.A. |
141 |
|||||
ITEM 16.B. |
141 |
|||||
ITEM 16.C. |
141 |
|||||
ITEM 16.D. |
141 |
|||||
ITEM 16.E. |
141 |
|||||
ITEM 16.F. |
142 |
|||||
ITEM 16.G. |
142 |
|||||
ITEM 16.H. |
142 |
|||||
ITEM 16.I. |
142 |
|||||
143 |
||||||
ITEM 17. |
143 |
|||||
ITEM 18. |
143 |
|||||
ITEM 19. |
143 |
• | “ADSs” refers to the American depositary shares, each representing 4.5 Class A ordinary shares; |
• | “Boqii,” “we,” “us,” “our company,” “the Company,” “the Group” and “our” refer to Boqii Holding Limited, a Cayman Islands exempted company and its subsidiaries and, in the context of describing our operations and consolidated financial information, its VIEs; |
• | “Boqii Corporation” refers to Boqii Corporation Limited; |
• | “Boqii International” refers to Boqii International Limited; |
• | “brand owner” refers to a company engaging in the production and sale of branded pet goods; |
• | “brand partner” refers to a specific brand owner whose products are sold via our online sales platforms and offline network; |
• | “CAGR” refers to compound annual growth rate; |
• | “Class A ordinary shares” refers to our Class A ordinary shares, par value US$0.001 per share; |
• | “Class B ordinary shares” refers to our Class B ordinary shares, par value US$0.001 per share; |
• | “China” or “PRC” refers to the People’s Republic of China, excluding, for the purpose of this annual report only, Taiwan, Hong Kong and Macau; |
• | “Chongni Network” refers to Chongni network technology (Shanghai) Co., Ltd; |
• | “Cuida” refers to Nanjing Cuida Biotechnology Co. Ltd.; |
• | “GMV” refers to gross merchandise volume, which is the total value of confirmed orders placed with us and sold through distribution model or drop shipping model where we act as a principal in the transaction regardless of whether the products are delivered or returned, calculated based on the listed prices of the ordered products without taking into consideration any discounts. With respect to products sold by Xingmu, such GMV is calculated based on the suggested retail prices of the ordered products without taking into consideration any discounts and regardless of whether the products are delivered or returned. For the avoidance of doubt, the total GMV amounts disclosed in this annual report (i) includes GMV of products sold by Xingmu, (ii) excludes products sold through consignment model and (iii) excludes the value of services offered by us; |
• | “Guangcheng Technology” refers to Shanghai Guangcheng Information Technology Co., Ltd.; |
• | “KOL” refers to key opinion leaders, or individuals who have the power to engage and impact people within a specific community or field; |
• | “MAU” refers to monthly active user, or the aggregate number of unique devices that were used to access our online platforms at least once in a given month. Our MAUs are calculated using internal company data, treating each distinguishable device as a separate MAU even though some users may access our platforms using more than one device and multiple users may access our platforms using the same device; |
• | “online platforms” refers to our online sales platforms and our content platform; |
• | “online sales platforms” refer to Boqii Mall, our flagship stores on third-party e-commerce platforms and our proprietary SaaS system; |
• | “PetDog” or “Beijing PetDog” refer to Beijing PetDog Technology Development Co., Ltd.; |
• | “MAA” means the twelfth amended and restated memorandum and articles of association of our company currently effective; |
• | “RMB” or “Renminbi” refers to the legal currency of the People’s Republic of China; |
• | “Shanghai Guangcheng” refers to Guangcheng (Shanghai) Information Technology Co., Ltd.; |
• | “Shanghai Xincheng” refers to Xincheng (Shanghai) Information Technology Co., Ltd.; |
• | “Shanghai Yiqin” refers to Shanghai Yiqin Pet Products Co., Ltd.; |
• | “shares” or “ordinary shares” refers to our Class A and Class B ordinary shares, par value US$0.0001 per share; |
• | “Shuangan” refers to Qingdao Shuangan Biotechnology Co., Ltd.; |
• | “Suzhou Taicheng” refers to Suzhou Taicheng Supply Chain Co., Ltd.; |
• | “US$,” “dollars” or “U.S. dollars” refers to the legal currency of the United States; |
• | “variable interest entities,” or “VIEs,” refers to the PRC entities of which we have power to control the management, and financial and operating policies and have the right to recognize and receive substantially all the economic benefits and in which we have an exclusive option to purchase all or part of the equity interests at the minimum price possible to the extent permitted by PRC law; |
• | “Xingmu” or “Nanjing Xingmu” refers to Nanjing Xingmu Biotechnology Co., Ltd.; |
• | “Xingmu Group” refers to Xingmu Group Limited; |
• | “Xingmu Holding” refers to Xingmu Holding Limited; |
• | “Xingmu HK” refers to Xingmu HK Limited; |
• | “Xingmu International” refers to Xingmu International Limited; |
• | “Xingmu WFOE” refers to Nanjing Xinmu Information Technology Co., Ltd.; |
• | “Yoken Holding” refers to Yoken Holding Limited; |
• | “Yoken International” refers to Yoken International Limited; and |
• | “Yoken WFOE” refers to Chengdu Chongaita Information Technology Co., Ltd.; |
• | our mission and strategies; |
• | our future business development, financial conditions and results of operations; |
• | the expected growth of the online retail and pet industries in China; |
• | our expectations regarding demand for and market acceptance of our products and services; |
• | our expectations regarding keeping and strengthening our relationships with customers, users, KOLs, brand partners, manufacturers, strategic partners, offline pet stores and pet hospitals and other stakeholders; |
• | competition in our industry; |
• | general economic and business condition in China; and |
• | relevant government policies and regulations relating to our industry. |
Equity interest | ||
Contractual arrangements, including the exclusive technical consulting and service agreement, intellectual property license agreement, equity pledge agreement, exclusive call option agreement, shareholders’ voting rights proxy agreement and loan agreement. See “—Contractual Arrangements with the VIEs and their Respective Shareholders.” |
• | the ownership structures of the VIEs do not and will not contravene any PRC laws or regulations currently in effect; and |
• | the agreements under the contractual arrangements among Shanghai Xincheng, Shanghai Guangcheng and their respective shareholders, among Xingmu WFOE, Nanjing Xingmu and their respective shareholders, as well as among Shanghai Xincheng, Suzhou Taicheng and their respective shareholders governed by PRC laws are valid and binding upon each party to such agreements and enforceable against each party thereto in accordance with their terms and applicable PRC laws and regulations currently in effect. |
• | Our limited operating history across our various business initiatives makes it difficult to evaluate our business prospects and future growth rate. |
• | We have a history of net losses and may continue to incur losses in the future. |
• | We have significant working capital requirements and have historically experienced working capital deficits. If we continue to experience such working capital deficits in the future, our business, liquidity, financial condition and results of operations may be materially and adversely affected. |
• | If we are unable to diversify our monetization channels, our business and prospects may be materially and adversely affected. |
• | Our business, prospects and financial results may be affected by our relationship with third-party e-commerce platforms. |
• | Our business is subject to the changing preferences and needs of our customers and their pets. Any failure by us to timely adapt our offerings according to changes in customer preferences may adversely affect our business and results of operations. |
• | If we fail to acquire and retain new customers, or fail to do so in a cost-effective manner, our business, financial condition and results of operations may be materially and adversely affected. |
• | There are substantial uncertainties regarding the interpretation and application of current and future PRC laws, regulations, and rules relating to the agreements that establish the VIE structure for our operations in China, including potential future actions by the PRC government, which could affect the enforceability of our contractual arrangements with the VIEs and, consequently, significantly affect our financial condition and results of operations. If the PRC government finds our contractual arrangements noncompliant with relevant PRC laws, regulations, and rules, or if these laws, regulations, and rules or the interpretation thereof change in the future, we could be subject to severe penalties or be forced to relinquish our interests in the VIEs. |
• | Any failure by any of the VIEs or their shareholders to perform their respective obligations under our contractual arrangements with them would have a material and adverse effect on our business. |
• | We rely on contractual arrangements with the VIEs and their respective shareholders for our business operations, which may not be as effective as direct ownership in providing operational control. |
• | The approval, filing or other requirements of the China Securities Regulatory Commission or other PRC government authorities may be required under PRC law in connection with our issuance of securities overseas or maintenance of the listing status of our ADSs, and the PRC government’s oversight and discretion over our business operations could result in a material adverse change in our operations and the value of our ADSs. |
• | Uncertainties exist with respect to the interpretation and implementation of the newly enacted Foreign Investment Law and how it may impact our business, financial condition and results of operations. |
• | Our contractual arrangements are governed by PRC law. Accordingly, these contracts would be interpreted in accordance with PRC law, and any disputes would be resolved in accordance with PRC legal procedures. |
• | Changes in China’s economic, political or social conditions or government policies could have a material adverse effect on our business and operations. |
• | Our business, financial condition and results of operations depend on the level of consumer confidence and spending in China and may be adversely affected by the downturn in the global or Chinese economy. |
• | Uncertainties with respect to the PRC legal system could adversely affect us. |
• | Any failure or perceived failure by us to comply with Anti-monopoly Guidelines for Internet Platforms and other Anti-monopoly laws and regulations may result in governmental investigations or enforcement actions, litigation or claims against us and could have an adverse effect on our business, financial condition and results of operations. |
• | You may experience difficulties in effecting service of legal process, enforcing foreign judgments or bringing actions in China against us or our management named in the prospectus based on foreign laws. |
• | It may be difficult for overseas regulators to conduct investigation or collect evidence within China. |
• | Our ADSs will be prohibited from trading in the United States under the Holding Foreign Companies Accountable Act, or the HFCAA, in 2024 if the PCAOB is unable to inspect or fully investigate auditors located in China, or in 2023 if proposed changes to the law are enacted. The delisting of our ADSs, or the threat of their being delisted, may materially and adversely affect the value of your investment. |
• | The potential enactment of the Accelerating Holding Foreign Companies Accountable Act would decrease the number of noninspection years from three years to two years, thus reducing the time period before our ADSs may be delisted or prohibited from over-the-counter over-the-counter |
• | We face possible delisting by the NYSE due to non-compliance with the continued listing standards of the NYSE. |
• | The trading price of the ADSs is likely to be volatile, which could result in substantial losses to investors. |
• | The dual-class structure of our ordinary shares may adversely affect the trading market for our ADSs. |
• | If securities or industry analysts do not publish research or reports about our business, or if they adversely change their recommendations regarding the ADSs, the market price for the ADSs and trading volume could decline. |
• | The sale or availability for sale of substantial amounts of ADSs could adversely affect their market price. |
• | Techniques employed by short sellers may drive down the market price of the ADSs. |
• | Due to our ADS’s price fluctuations, there is a significant risk that we will be a passive foreign investment company, or a PFIC, for the current or any future taxable year, which could result in adverse U.S. federal income tax consequences to U.S. investors in the ADSs or our Class A ordinary shares. |
• | maintain superior customer experience; |
• | maintain a diverse selection of high-quality products; |
• | maintain and grow our customer base, online community user base and keep our users highly active and engaged; |
• | maintain and grow our content offerings and ensure access to high-quality content creators, especially KOLs; |
• | maintain and enhance our reputation and goodwill generally and in the event of any negative publicity on product quality, customer services, internet security, or other issues affecting us or our industry in China; |
• | maintain our relationships with brand partners, manufacturers, physical pet stores and pet hospitals and oversee the quality of products and services provided by these third parties; and |
• | maintain our relationships with KOLs and ensure that their behaviors represent our brands and products. |
• | the size and composition of our customer base; |
• | the number of brand partners and products that we feature; |
• | the quality and price of the products that we offer; |
• | our ability to customize content and product recommendations to customers tailored to their needs; |
• | the convenient shopping experience that we provide; |
• | our selling and marketing efforts, including our ability to promote the brands of our brand partners and our private label brands; and |
• | our reputation and brand strength. |
• | alleged misconduct or other improper activities committed by our shareholders, affiliates, directors, officers and other employees, as well as our brand partners, manufacturers, content creators, third-party platforms, delivery service providers and other third parties; |
• | allegations or rumors about us or our shareholders, affiliates, directors, officers and other employees, as well as our brand partners, manufacturers, content creators, third-party platforms, delivery service providers and other third parties; |
• | customer complaints about the quality of products and services provided by us or third parties we cooperate with; |
• | infringement activities associated with counterfeit goods on our platform; |
• | security breaches or customer data leakage; |
• | governmental and regulatory investigations or penalties resulting from our failure to comply with applicable laws and regulations; |
• | instances of product or service safety issues, even those not involving us or our business partners; and |
• | other lawsuits and legal proceedings, with or without merits. |
• | protecting the data in and hosted on our system, including against attacks on our system by outside parties or fraudulent behavior or improper use by our employees; |
• | addressing concerns related to privacy and sharing, safety, security and other factors; and |
• | complying with applicable laws, rules and regulations relating to the collection, use, storage, transfer, disclosure or security of personal information, including any requests from regulatory and government authorities relating to such data. |
• | revoking the business licenses and/or operating licenses of such entities; |
• | discontinuing or placing restrictions or onerous conditions on our operation through any transactions between our PRC subsidiaries and the VIEs; |
• | imposing fines on us, placing restrictions on our right to collect revenues, confiscating the income from our PRC subsidiaries or the VIEs, or imposing other requirements with which we or the VIEs may not be able to comply; |
• | requiring us to restructure our ownership structure or operations, including terminating the contractual arrangements with the VIEs and deregistering the equity pledges of the VIEs, which in turn would affect our ability to consolidate, derive economic interests from, or exert effective control over the VIEs; |
• | shutting down our servers or blocking our mobile apps and websites; |
• | requiring us to restructure the operations in such a way as to compel us to establish a new enterprise, reapply for the necessary licenses or relocate our businesses, staff and assets; |
• | imposing additional conditions or requirements with which we may not be able to comply; or |
• | taking other regulatory or enforcement actions against us that could be harmful to our business. |
• | actual or anticipated fluctuations in our results of operations, e.g., net revenues, earnings and cash flows; |
• | the financial projections we may provide to the public, any changes in these projections or our failure to meet these projections; |
• | announcements of significant technical innovations, new investments, acquisitions, strategic partnerships, joint ventures, results of operations or capital commitments by us or our competitors; |
• | announcements of new offerings, solutions and expansions by us or our competitors; |
• | failure of securities analysts to initiate or maintain coverage of our company, changes in financial estimates or ratings by any securities analysts who follow our company or our failure to meet these estimates or the expectations of investors; |
• | detrimental adverse publicity about us, our services or our industry; |
• | announcements of new regulations, rules or policies relevant to our business; |
• | additions or departures of key personnel; |
• | release of lock-up or other transfer restrictions on our outstanding equity securities or sales of additional equity securities; |
• | potential litigation or regulatory investigations; and |
• | other events or factors, including those resulting from war, epidemics, incidents of terrorism or responses to these events. |
• | the rules under the Exchange Act requiring the filing with the SEC of quarterly reports on Form 10-Q or current reports on Form 8-K; |
• | the sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations in respect of a security registered under the Exchange Act; |
• | the sections of the Exchange Act requiring insiders to file public reports of their stock ownership and trading activities and liability for insiders who profit from trades made in a short period of time; and |
• | the selective disclosure rules by issuers of material nonpublic information under Regulation FD. |
Taxation Scenario (1) |
||||
Statutory Tax and Standard Rates |
||||
Hypothetical pre-tax earnings(2) |
100.0 | % | ||
Tax on earnings at statutory rate of 25% (3) |
(25.0 | )% | ||
Net earnings available for distribution |
75.0 | % | ||
Withholding tax at standard rate of 10% (4) |
(7.5 | )% | ||
Net distribution to Boqii Holding Limited /shareholders |
67.5 | % |
(1) | For purposes of this example, the tax calculation has been simplified. The hypothetical book pre-tax earnings amount, not considering timing differences, is assumed to equal taxable income in China. |
(2) | Under the terms of VIE agreements, our PRC subsidiaries may charge the VIEs for services provided to VIEs. These fees shall be recognized as expenses of the VIEs, with a corresponding amount as service income by our PRC subsidiaries and eliminate in consolidation. For income tax purposes, our PRC subsidiaries and the VIEs file income tax returns on a separate company basis. The fees paid are recognized as a tax deduction by the VIEs and as income by our PRC subsidiaries and are tax neutral. |
(3) | Certain of our subsidiaries and the VIEs qualifies for a 15% preferential income tax rate in China. However, such rate is subject to qualification, is temporary in nature, and may not be available in a future period when distributions are paid. For purposes of this hypothetical example, the table above reflects a maximum tax scenario under which the full statutory rate would be effective. |
(4) | The PRC Enterprise Income Tax Law imposes a withholding income tax of 10% on dividends distributed by a foreign invested enterprise, or FIE, to its immediate holding company outside of China. A lower withholding income tax rate of 5% is applied if the FIE’s immediate holding company is registered in Hong Kong or other jurisdictions that have a tax treaty arrangement with China, subject to a qualification review at the time of the distribution. For purposes of this hypothetical example, the table above assumes a maximum tax scenario under which the full withholding tax would be applied. |
As of March 31, 2020 |
||||||||||||||||||||||||
Boqii Holding Limited |
All others |
Primary beneficiaries of VIEs and their subsidiaries |
VIEs and their subsidiaries |
Eliminating adjustments |
Consolidated totals |
|||||||||||||||||||
(RMB in thousands) |
||||||||||||||||||||||||
ASSETS |
||||||||||||||||||||||||
Current assets: |
||||||||||||||||||||||||
Cash and cash equivalents |
1,145 | 1,719 | 48,511 | 36,977 | — | 88,352 | ||||||||||||||||||
Accounts receivable, net |
— | 19,979 | 1,577 | 23,424 | — | 44,980 | ||||||||||||||||||
Inventories, net |
— | 6,319 | 18,337 | 38,400 | — | 63,056 | ||||||||||||||||||
Prepayments and other current assets |
125 | 32,209 | 6,245 | 38,141 | — | 76,720 | ||||||||||||||||||
Amounts due from related parties |
— | — | 1,230 | 4,752 | — | 5,982 | ||||||||||||||||||
Intra-Group receivables due from the Group’s entities(1) |
— | 18,374 | 356,546 | 22,332 | (397,252 | ) | — | |||||||||||||||||
Property and equipment, net |
— | 24 | 24 | 4,933 | — | 4,981 | ||||||||||||||||||
Intangible assets |
— | — | 32,223 | 1,315 | — | 33,538 | ||||||||||||||||||
Operating lease right-of-use |
— | — | 1,386 | 13,565 | — | 14,951 | ||||||||||||||||||
Goodwill |
— | — | 39,690 | 494 | — | 40,184 | ||||||||||||||||||
Long-term investments |
— | — | — | 73,432 | — | 73,432 | ||||||||||||||||||
Other noncurrent asset |
7,943 | 271 | 1,801 | 1,004 | — | 11,019 | ||||||||||||||||||
Total assets |
9,213 | 78,895 | 507,570 | 258,769 | (397,252 | ) | 457,195 | |||||||||||||||||
LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS’ EQUITY |
||||||||||||||||||||||||
Current liabilities |
||||||||||||||||||||||||
Short-term borrowings |
42,485 | — | 29,977 | 2,761 | — | 75,223 | ||||||||||||||||||
Accounts payable |
— | — | 31,714 | 56,291 | — | 88,005 | ||||||||||||||||||
Salary and welfare payable |
— | 196 | 480 | 3,789 | — | 4,465 | ||||||||||||||||||
Accrued liabilities and other current liabilities |
11,332 | 1,788 | 6,904 | 17,859 | — | 37,883 | ||||||||||||||||||
Amounts due to related parties, current |
— | — | — | 45 | — | 45 | ||||||||||||||||||
Other debts, current |
76,252 | — | — | — | — | 76,252 | ||||||||||||||||||
Contract liabilities |
— | 81 | — | 7,621 | — | 7,702 | ||||||||||||||||||
Operating lease liabilities, current |
— | — | 1,317 | 6,652 | — | 7,969 | ||||||||||||||||||
Derivative liabilities |
14,816 | (465 | ) | — | — | — | 14,351 | |||||||||||||||||
Intra-Group payables due to the Group’s entities(1) |
794 | — | 22,332 | 374,126 | (397,252 | ) | — | |||||||||||||||||
Deferred tax liabilities |
— | — | 7,998 | 2,593 | — | 10,591 | ||||||||||||||||||
Operating lease liabilities, noncurrent |
— | — | — | 5,375 | — | 5,375 | ||||||||||||||||||
Long-term borrowings |
4,957 | — | 47,209 | 982 | — | 53,148 | ||||||||||||||||||
Amounts due to related parties, noncurrent |
— | 1,071 | — | 10,450 | — | 11,521 | ||||||||||||||||||
Other debts, noncurrent — |
— | — | 18,000 | 147,774 | — | 165,774 | ||||||||||||||||||
Investments deficit to the Group’s entities(2) |
3,427 | 79,651 | 384,401 | — | (467,479 | ) | — | |||||||||||||||||
Total liabilities |
154,063 | 82,322 | 550,332 | 636,318 | (864,731 | ) | 558,304 | |||||||||||||||||
Mezzanine equity: |
||||||||||||||||||||||||
Mezzanine Equity |
1,952,705 | — | — | — | — | 1,952,705 | ||||||||||||||||||
Redeemable noncontrolling interests |
(94,758 | ) | — | — | — | — | (94,758 | ) | ||||||||||||||||
Total mezzanine equity |
1,857,947 | — | — | — | — | 1,857,947 | ||||||||||||||||||
Shareholders’ equity: |
||||||||||||||||||||||||
Total Boqii Holding Limited shareholders’ equity |
(2,002,797 | ) | (3,427 | ) | (79,651 | ) | (384,401 | ) | 467,479 | (2,002,797 | ) | |||||||||||||
Noncontrolling interests |
— | — | 36,889 | 6,852 | — | 43,741 | ||||||||||||||||||
Total shareholders’ equity |
(2,002,797 | ) | (3,427 | ) | (42,762 | ) | (377,549 | ) | 467,479 | (1,959,056 | ) | |||||||||||||
Total liabilities, mezzanine equity and shareholders’ equity |
9,213 | 78,895 | 507,570 | 258,769 | (397,252 | ) | 457,195 | |||||||||||||||||
As of March 31, 2021 |
||||||||||||||||||||||||
Boqii Holding Limited |
All others |
Primary Beneficiaries of VIEs and their subsidiaries |
VIEs and their subsidiaries |
Eliminating adjustments |
Consolidated totals |
|||||||||||||||||||
(RMB in thousands) |
||||||||||||||||||||||||
ASSETS |
||||||||||||||||||||||||
Current assets: |
||||||||||||||||||||||||
Cash and cash equivalents |
18,285 | 146,671 | 109,395 | 17,886 | — | 292,237 | ||||||||||||||||||
short-term investments |
— | 118,546 | 50,000 | — | — | 168,546 | ||||||||||||||||||
Accounts receivable, net |
— | 13,015 | 5,324 | 27,393 | — | 45,732 | ||||||||||||||||||
Inventories, net |
— | 14,411 | 65,791 | 11,349 | — | 91,551 | ||||||||||||||||||
Prepayments and other current assets |
2,638 | 42,183 | 6,995 | 33,445 | — | 85,261 | ||||||||||||||||||
Amounts due from related parties |
— | — | — | 11,465 | — | 11,465 | ||||||||||||||||||
Intra-Group receivables due from the Group’s entities(1) |
— | 44,632 | 574,610 | 47,592 | (666,834 | ) | — | |||||||||||||||||
Property and equipment, net |
— | 14 | — | 8,372 | — | 8,386 | ||||||||||||||||||
Intangible assets |
— | — | 28,628 | 909 | — | 29,537 | ||||||||||||||||||
Operating lease right-of-use |
— | — | 1,498 | 27,736 | — | 29,234 | ||||||||||||||||||
Goodwill |
— | — | 39,690 | 494 | — | 40,184 | ||||||||||||||||||
Long-term investments |
— | — | — | 74,330 | — | 74,330 | ||||||||||||||||||
Other noncurrent asset |
344 | 317 | 1,017 | 2,433 | — | 4,111 | ||||||||||||||||||
Long-term investments to the Group’s entities(2) |
66,868 | — | — | — | (66,868 | ) | — | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total assets |
88,135 | 379,789 | 882,948 | 263,404 | (733,702 | ) | 880,574 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS’ EQUITY |
||||||||||||||||||||||||
Current liabilities |
||||||||||||||||||||||||
Short-term borrowings |
— | 32,857 | 49,225 | 3,484 | — | 85,566 | ||||||||||||||||||
Accounts payable |
— | 264 | 41,644 | 29,940 | — | 71,848 | ||||||||||||||||||
Salary and welfare payable |
— | 738 | 720 | 4,851 | — | 6,309 | ||||||||||||||||||
Accrued liabilities and other current liabilities |
4,055 | 677 | 787 | 24,536 | — | 30,055 | ||||||||||||||||||
Amounts due to related parties, current |
— | — | — | 910 | — | 910 | ||||||||||||||||||
Contract liabilities |
— | — | 160 | 3,706 | — | 3,866 | ||||||||||||||||||
Operating lease liabilities, current |
— | — | 2,005 | 6,058 | — | 8,063 | ||||||||||||||||||
Derivative liabilities |
444 | 9,362 | 190 | — | — | 9,996 | ||||||||||||||||||
Intra-Group payables due to the Group’s entities(1) |
962 | 19,188 | 35,572 | 611,112 | (666,834 | ) | — | |||||||||||||||||
Deferred tax liabilities |
— | — | 7,106 | 1,852 | — | 8,958 | ||||||||||||||||||
Operating lease liabilities, non-current |
— | — | — | 19,997 | — | 19,997 | ||||||||||||||||||
Long-term borrowings |
— | — | 67,203 | 872 | — | 68,075 | ||||||||||||||||||
Amounts due to related parties, non-current |
— | — | — | — | — | — | ||||||||||||||||||
Other debts, noncurrent |
— | — | 18,170 | 415,122 | — | 433,292 | ||||||||||||||||||
Investments deficit to the Group’s entities(2) |
— | 243,889 | 865,920 | — | (1,109,809 | ) | — | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total liabilities |
5,461 |
306,975 |
1,088,702 |
1,122,440 |
(1,776,643 |
) |
746,935 |
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Mezzanine equity: |
||||||||||||||||||||||||
Redeemable noncontrolling interests |
— | 5,946 | — | — | — | 5,946 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total mezzanine equity |
— |
5,946 |
— |
— |
— |
5,946 |
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Shareholders’ equity: |
||||||||||||||||||||||||
Total Boqii Holding Limited shareholders’ equity |
82,674 | 66,868 | (243,889 | ) | (865,920 | ) | 1,042,941 | 82,674 | ||||||||||||||||
Noncontrolling interests |
— | — | 38,135 | 6,884 | — | 45,019 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total shareholders’ equity |
82,674 |
66,868 |
(205,754 |
) |
(859,036 |
) |
1,042,941 |
127,693 |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total liabilities, mezzanine equity and shareholders’ equity |
88,135 |
379,789 |
882,948 |
263,404 |
(733,702 |
) |
880,574 |
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
As of March 31, 2022 |
||||||||||||||||||||||||
Boqii Holding Limited |
All others |
Primary Beneficiaries of VIEs and their subsidiaries |
VIEs and their subsidiaries |
Eliminating adjustments |
Consolidated totals |
|||||||||||||||||||
(RMB in thousands) |
||||||||||||||||||||||||
ASSETS |
||||||||||||||||||||||||
Current assets: |
||||||||||||||||||||||||
Cash and cash equivalents |
1,166 | 112,876 | 28,246 | 20,567 | — | 162,855 | ||||||||||||||||||
short-term investments |
— | 128,084 | — | — | — | 128,084 | ||||||||||||||||||
Accounts receivable, net |
— | 2,704 | 15,092 | 31,435 | — | 49,231 | ||||||||||||||||||
Inventories, net |
— | 4,777 | 89,130 | 16,014 | — | 109,921 | ||||||||||||||||||
Prepayments and other current assets |
9,727 | 13,154 | 36,750 | 57,107 | — | 116,738 | ||||||||||||||||||
Amounts due from related parties |
— | — | — | 11,726 | — | 11,726 | ||||||||||||||||||
Intra-Group receivables due from the Group’s entities(1) |
— | 80,224 | 896,341 | 16,535 | (993,100 | ) | — | |||||||||||||||||
Property and equipment, net |
— | 61 | 1,003 | 6,715 | — | 7,779 | ||||||||||||||||||
Intangible assets |
— | — | 25,037 | 507 | — | 25,544 | ||||||||||||||||||
Operating lease right-of-use |
— | — | 2,879 | 35,688 | — | 38,567 | ||||||||||||||||||
Goodwill |
— | — | 39,690 | 994 | — | 40,684 | ||||||||||||||||||
Long-term investments |
670 | — | — | 81,649 | — | 82,319 | ||||||||||||||||||
Other noncurrent asset |
— | 306 | 1,166 | 3,389 | — | 4,861 | ||||||||||||||||||
Long-term investments to the Group’s entities(2) |
189,471 | — | — | — | (189,471 | ) | — | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total assets |
201,034 |
342,186 |
1,135,334 |
282,326 |
(1,182,571 |
) |
778,309 |
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS’ EQUITY |
||||||||||||||||||||||||
Current liabilities |
||||||||||||||||||||||||
Short-term borrowings |
— | 31,741 | 128,513 | 872 | — | 161,126 | ||||||||||||||||||
Accounts payable |
— | 39 | 39,041 | 55,144 | — | 94,224 | ||||||||||||||||||
Salary and welfare payable |
— | 827 | 447 | 5,597 | — | 6,871 | ||||||||||||||||||
Accrued liabilities and other current liabilities |
349 | 1,189 | — | 25,786 | — | 27,324 | ||||||||||||||||||
Amounts due to related parties, current |
— | — | 215 | 4 | — | 219 | ||||||||||||||||||
Contract liabilities |
— | — | — | 7,007 | — | 7,007 | ||||||||||||||||||
Operating lease liabilities, current |
— | — | 2,763 | 7,238 | — | 10,001 | ||||||||||||||||||
Derivative liabilities |
— | 9,086 | — | — | — | 9,086 | ||||||||||||||||||
Intra-Group payables due to the Group’s entities(1) |
1,510 | 12,123 | 33,507 | 945,960 | (993,100 | ) | — | |||||||||||||||||
Deferred tax liabilities |
— | — | 6,216 | (1,369 | ) | — | 4,847 | |||||||||||||||||
Operating lease liabilities, non-current |
— | — | — | 28,197 | — | 28,197 | ||||||||||||||||||
Other debts, noncurrent |
— | — | 23,188 | 157,874 | — | 181,062 | ||||||||||||||||||
Investments deficit to the Group’s entities(2) |
— | 91,196 | 955,158 | — | (1,046,354 | ) | — | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total liabilities |
1,859 |
146,201 |
1,189,048 |
1,232,310 |
(2,039,454 |
) |
529,964 |
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Mezzanine equity: |
||||||||||||||||||||||||
Redeemable noncontrolling interests |
— | 6,522 | — | — | — | 6,522 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total mezzanine equity |
— |
6,522 |
— |
— |
— |
6,522 |
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Shareholders’ equity: |
||||||||||||||||||||||||
Total Boqii Holding Limited shareholders’ equity |
199,175 | 189,471 | (91,196 | ) | (955,158 | ) | 856,883 | 199,175 | ||||||||||||||||
Noncontrolling interests |
— | (8 | ) | 37,482 | 5,174 | — | 42,648 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total shareholders’ equity |
199,175 |
189,463 |
(53,714 |
) |
(949,984 |
) |
856,883 |
241,823 |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total liabilities, mezzanine equity and shareholders’ equity |
201,034 |
342,186 |
1,135,334 |
282,326 |
(1,182,571 |
) |
778,309 |
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
(1) | Represents the elimination of intercompany balances among Boqii Holding Limited, the Primary Beneficiaries of VIEs and their subsidiaries, the Other Subsidiaries, and the VIEs and their subsidiaries that we consolidate. |
(2) | Represents the elimination of investments among Boqii Holding Limited, the Primary Beneficiaries of VIEs and their subsidiaries, the Other Subsidiaries, and the VIEs and their subsidiaries that we consolidate. |
Year Ended March 31, 2020 |
||||||||||||||||||||||||
Boqii Holding Limited |
All others |
Primary Beneficiaries of VIEs and their subsidiaries |
VIEs and their subsidiaries |
Eliminating adjustments |
Consolidated totals |
|||||||||||||||||||
(RMB in thousands) |
||||||||||||||||||||||||
Net revenues: |
||||||||||||||||||||||||
Third-party revenues |
— | 45,084 | 145,788 | 579,365 | — | 770,237 | ||||||||||||||||||
Intra-Group revenues(1) |
— | — | 282,210 | 92,728 | (374,938 | ) | — | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total revenues |
— |
45,084 |
427,998 |
672,093 |
(374,938 |
) |
770,237 |
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Cost of revenues: |
||||||||||||||||||||||||
Third-party cost of revenues |
— | (36,798 | ) | (347,714 | ) | (226,958 | ) | — | (611,470 | ) | ||||||||||||||
Intra-Group cost of revenues(1) |
— | — | (36,048 | ) | (282,210 | ) | 318,258 | — | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total cost of revenues |
— |
(36,798 |
) |
(383,762 |
) |
(509,168 |
) |
318,258 |
(611,470 |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Gross profit |
— |
8,286 |
44,236 |
162,925 |
(56,680 |
) |
158,767 |
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Operating expenses: |
||||||||||||||||||||||||
Third-party operating expenses |
(4,631 | ) | (11,771 | ) | (52,491 | ) | (229,658 | ) | — | (298,551 | ) | |||||||||||||
Intra-Group operating expenses(1) |
— | (12,000 | ) | (44,680 | ) | — | 56,680 | — | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total operating expenses |
(4,631 |
) |
(23,771 |
) |
(97,171 |
) |
(229,658 |
) |
56,680 |
(298,551 |
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Other income, net |
— | — | 710 | 1,688 | — | 2,398 | ||||||||||||||||||
Loss from operations |
(4,631 |
) |
(15,485 |
) |
(52,225 |
) |
(65,045 |
) |
— |
(137,386 |
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Equity in loss of the Group’s entities(2) |
(134,660 | ) | (117,716 | ) | (63,921 | ) | — | 316,297 | — | |||||||||||||||
Nonoperating income/(expense) |
(39,733 | ) | (1,459 | ) | (583 | ) | 3,236 | — | (38,539 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Loss before income tax expenses |
(179,024 |
) |
(134,660 |
) |
(116,729 |
) |
(61,809 |
) |
316,297 |
(175,925 |
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Income tax benefits |
— | — | 371 | 141 | — | 512 | ||||||||||||||||||
Share of results of equity investees |
— | — | (383 | ) | (137 | ) | — | (520 | ) | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net loss |
(179,024 |
) |
(134,660 |
) |
(116,741 |
) |
(61,805 |
) |
316,297 |
(175,933 |
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Less: Net income attributable to the noncontrolling interest shareholders |
— | — | 975 | 2,116 | — | 3,091 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net loss attributable to Boqii Holding Limited |
(179,024 |
) |
(134,660 |
) |
(117,716 |
) |
(63,921 |
) |
316,297 |
(179,024 |
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31, 2021 |
||||||||||||||||||||||||
Boqii Holding Limited |
All others |
Primary Beneficiaries of VIEs and their subsidiaries |
VIEs and their subsidiaries |
Eliminating adjustments |
Consolidated totals |
|||||||||||||||||||
(RMB in thousands) |
||||||||||||||||||||||||
Net revenues: |
||||||||||||||||||||||||
Third-party revenues |
— | 121,190 | 154,277 | 735,518 | — | 1,010,985 | ||||||||||||||||||
Intra-Group revenues(1) |
— | — | 406,049 | 48,374 | (454,423 | ) | — | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total revenues |
— |
121,190 |
560,326 |
783,892 |
(454,423 |
) |
1,010,985 |
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Cost of revenues: |
||||||||||||||||||||||||
Third-party cost of revenues |
— | (94,519 | ) | (356,692 | ) | (372,475 | ) | — | (823,686 | ) | ||||||||||||||
Intra-Group cost of revenues(1) |
— | — | (132,173 | ) | (297,844 | ) | 430,017 | — | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total cost of revenues |
— |
(94,519 |
) |
(488,865 |
) |
(670,319 |
) |
430,017 |
(823,686 |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Gross profit |
— |
26,671 |
71,461 |
113,573 |
(24,406 |
) |
187,299 |
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Operating expenses: |
||||||||||||||||||||||||
Third-party operating expenses |
(19,320 | ) | (34,391 | ) | (85,699 | ) | (254,951 | ) | — | (394,361 | ) | |||||||||||||
Intra-Group operating expenses(1) |
— | — | (17,149 | ) | (7,257 | ) | 24,406 | — | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total operating expenses |
(19,320 |
) |
(34,391 |
) |
(102,848 |
) |
(262,208 |
) |
24,406 |
(394,361 |
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Other income, net |
— | — | 56 | 1,011 | — | 1,067 | ||||||||||||||||||
Loss from operations |
(19,320 |
) |
(7,720 |
) |
(31,331 |
) |
(147,624 |
) |
— |
(205,995 |
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Equity in loss of the Group’s entities(2) |
(199,065 | ) | (196,170 | ) | (166,484 | ) | — | 561,719 | — | |||||||||||||||
Nonoperating income/(expense) |
23,941 | 4,825 | 2,000 | (18,162 | ) | — | 12,604 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Loss before income tax expenses |
(194,444 |
) |
(199,065 |
) |
(195,815 |
) |
(165,786 |
) |
561,719 |
(193,391 |
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Income tax benefits |
— | — | 891 | (20 | ) | — | 871 | |||||||||||||||||
Share of results of equity investees |
— | — | — | (696 | ) | — | (696 | ) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net loss |
(194,444 |
) |
(199,065 |
) |
(194,924 |
) |
(166,502 |
) |
561,719 |
(193,216 |
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Less: Net income attributable to the noncontrolling interest shareholders |
— | — | 1,246 | (18 | ) | — | 1,228 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net loss attributable to Boqii Holding Limited |
(194,444 |
) |
(199,065 |
) |
(196,170 |
) |
(166,484 |
) |
561,719 |
(194,444 |
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31, 2022 |
||||||||||||||||||||||||
Boqii Holding Limited |
All others |
Primary Beneficiaries of VIEs and their subsidiaries |
VIEs and their subsidiaries |
Eliminating adjustments |
Consolidated totals |
|||||||||||||||||||
(RMB in thousands) |
||||||||||||||||||||||||
Net revenues: |
||||||||||||||||||||||||
Third-party revenues |
— | 42,769 | 266,280 | 877,380 | — | 1,186,429 | ||||||||||||||||||
Intra-Group revenues(1) |
— | — | 550,585 | 56,079 | (606,664 | ) | — | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total revenues |
— |
42,769 |
816,865 |
933,459 |
(606,664 |
) |
1,186,429 |
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Cost of revenues: |
||||||||||||||||||||||||
Third-party cost of revenues |
— | (38,202 | ) | (744,834 | ) | (160,661 | ) | — | (943,697 | ) | ||||||||||||||
Intra-Group cost of revenues(1) |
— | (638 | ) | (1,761 | ) | (550,585 | ) | 552,983 | (1 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total cost of revenues |
— |
(38,840 |
) |
(746,595 |
) |
(711,246 |
) |
552,983 |
(943,698 |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Gross profit |
— |
3,929 |
70,270 |
222,213 |
(53,681 |
) |
242,731 |
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Operating expenses: |
||||||||||||||||||||||||
Third-party operating expenses |
(17,058 | ) | (21,896 | ) | (54,015 | ) | (288,291 | ) | — | (381,260 | ) | |||||||||||||
Intra-Group operating expenses(1) |
— | — | (53,681 | ) | — | 53,681 | — | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total operating expenses |
(17,058 |
) |
(21,896 |
) |
(107,696 |
) |
(288,291 |
) |
53,681 |
(381,260 |
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Other income, net |
— | — | 182 | 98 | — | 280 | ||||||||||||||||||
Loss from operations |
(17,058 |
) |
(17,967 |
) |
(37,244 |
) |
(65,980 |
) |
— |
(138,249 |
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Equity in loss of the Group’s entities(2) |
(132,683 | ) | (115,665 | ) | (81,790 | ) | — | 330,138 | — | |||||||||||||||
Nonoperating income/(expense) |
21,351 | 941 | 1,825 | (20,680 | ) | — | 3,437 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Loss before income tax expenses |
(128,390 |
) |
(132,691 |
) |
(117,209 |
) |
(86,660 |
) |
330,138 |
(134,812 |
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Income tax benefits |
— | — | 890 | 681 | — | 1,571 | ||||||||||||||||||
Share of results of equity investees |
— | — | — | 418 | — | 418 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net loss |
(128,390 |
) |
(132,691 |
) |
(116,319 |
) |
(85,561 |
) |
330,138 |
(132,823 |
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Less: Net income attributable to the noncontrolling interest shareholders |
— | (8 | ) | (654 | ) | (3,771 | ) | — | (4,433 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net loss attributable to Boqii Holding Limited |
(128,390 |
) |
(132,683 |
) |
(115,665 |
) |
(81,790 |
) |
330,138 |
(128,390 |
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
(1) | Represents the elimination of the intercompany transactions at the consolidation level. For the years ended March 31, 2020, 2021 and 2022, the primary beneficiary of the VIE didn’t charge any service fees according to the exclusive consultation and service agreements. |
(2) | Represents the elimination of investments among Boqii Holding Limited, the primary beneficiaries of VIEs and their subsidiaries, the Other Subsidiaries, and the VIEs and their subsidiaries that we consolidate. |
Year Ended March 31, 2020 |
||||||||||||||||||||||||
Boqii Holding Limited |
All others |
Primary Beneficiaries of VIEs and their subsidiaries |
VIEs and their subsidiaries |
Eliminating adjustments |
Consolidated totals |
|||||||||||||||||||
(RMB in thousands) |
||||||||||||||||||||||||
Cash flows from operating activities: |
||||||||||||||||||||||||
Net cash provided by/(used in) transactions with external parties |
— | (58,790 | ) | (233,346 | ) | 126,224 | — | (165,912 | ) | |||||||||||||||
Net cash provided by/(used in) transactions with the Group’s entities |
— | (1,169 | ) | 105,294 | (104,125 | ) | — | — | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net cash provided by/(used in) operating activities |
— | (59,959 | ) | (128,052 | ) | 22,099 | — | (165,912 | ) | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Cash flows from investing activities: |
||||||||||||||||||||||||
Capital contribution to the Group’s entities |
(158,101 | ) | (112,071 | ) | — | — | 270,172 | — | ||||||||||||||||
Cash flows of loan funding provided to the Group’s entities, net of repayments received |
— | 11,312 | 18,086 | 21,156 | (50,554 | ) | — | |||||||||||||||||
Other investing activities |
(26,253 | ) | (7,355 | ) | 23,143 | (64,591 | ) | — | (75,056 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net cash provided by/(used in) investing activities |
(184,354 | ) | (108,114 | ) | 41,229 | (43,435 | ) | 219,618 | (75,056 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Cash flows from financing activities: |
||||||||||||||||||||||||
Capital contribution from the Group’s entities |
— | 158,101 | 112,071 | — | (270,172 | ) | — | |||||||||||||||||
Cash flows of loan funding received from the Group’s entities, net of repayments made |
— | — | (21,156 | ) | (29,398 | ) | 50,554 | — | ||||||||||||||||
Other financing activities |
155,712 | 18,000 | 47,694 | 73,626 | — | 295,032 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net cash provided by financing activities |
155,712 | 176,101 | 138,609 | 44,228 | (219,618 | ) | 295,032 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31, 2021 |
||||||||||||||||||||||||
Boqii Holding Limited |
All others |
Primary Beneficiaries of VIEs and their subsidiaries |
VIEs and their subsidiaries |
Eliminating adjustments |
Consolidated totals |
|||||||||||||||||||
(RMB in thousands) |
||||||||||||||||||||||||
Cash flows from operating activities: |
||||||||||||||||||||||||
Net cash provided by/(used in) transactions with external parties |
2,193 | (161,806 | ) | (507,640 | ) | 419,767 | — | (247,486 | ) | |||||||||||||||
Net cash provided by/(used in) transactions with the Group’s entities |
34 | (6,552 | ) | 337,582 | (331,064 | ) | — | — | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net cash provided by/(used in) operating activities |
2,227 | (168,358 | ) | (170,058 | ) | 88,703 | — | (247,486 | ) | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Cash flows from investing activities: |
||||||||||||||||||||||||
Capital contribution to the Group’s entities |
(620,373 | ) | (148,624 | ) | — | — | 768,997 | — | ||||||||||||||||
Cash flows of loan funding provided to the Group’s entities, net of repayments received |
— | 38,859 | (80,577 | ) | (5,242 | ) | 46,960 | — | ||||||||||||||||
Other investing activities |
(18,613 | ) | (45,942 | ) | (87,890 | ) | (31,972 | ) | — | (184,417 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net cash used in investing activities |
(638,986 | ) | (155,707 | ) | (168,467 | ) | (37,214 | ) | 815,957 | (184,417 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Cash flows from financing activities: |
||||||||||||||||||||||||
Proceeds from the initial public offering, net of underwriter discounts and commissions and other offering costs paid |
393,698 | — | — | — | — | 393,698 | ||||||||||||||||||
Capital contribution from the Group’s entities |
— | 452,553 | 316,444 | — | (768,997 | ) | — | |||||||||||||||||
Cash flows of loan funding received from the Group’s entities, net of repayments made |
— | — | 5,243 | 41,717 | (46,960 | ) | — | |||||||||||||||||
Other financing activities |
266,668 | 19,845 | 80,431 | (112,151 | ) | — | 254,793 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net cash provided by/(used in) financing activities |
660,366 | 472,398 | 402,118 | (70,434 | ) | (815,957 | ) | 648,491 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31, 2022 |
||||||||||||||||||||||||
Boqii Holding Limited |
All others |
Primary Beneficiaries of VIEs and their subsidiaries |
VIEs and their subsidiaries |
Eliminating adjustments |
Consolidated totals |
|||||||||||||||||||
(RMB in thousands) |
||||||||||||||||||||||||
Cash flows from operating activities: |
||||||||||||||||||||||||
Net cash provided by/(used in) transactions with external parties |
(3,626 | ) | 16,466 | (686,545 | ) | 526,201 | — | (147,504 | ) | |||||||||||||||
Net cash provided by/(used in) transactions with the Group’s entities |
563 | (29 | ) | 328,791 | (329,325 | ) | — | — | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net cash provided by/(used in) operating activities |
(3,063 | ) | 16,437 | (357,754 | ) | 196,876 | — | (147,504 | ) | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Cash flows from investing activities: |
||||||||||||||||||||||||
Capital contribution to the Group’s entities |
(242,713 | ) | (252,255 | ) | — | — | 494,968 | — | ||||||||||||||||
Cash flows of loan funding provided to the Group’s entities, net of repayments received |
— | (22,616 | ) | (91,552 | ) | 6,294 | 107,874 | — | ||||||||||||||||
Other investing activities |
(34,687 | ) | (9,593 | ) | 83,909 | (18,482 | ) | — | 21,147 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net cash provided by/(used in) investing activities |
(277,400 | ) | (284,464 | ) | (7,643 | ) | (12,188 | ) | 602,842 | 21,147 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Cash flows from financing activities: |
||||||||||||||||||||||||
Capital contribution from the Group’s entities |
— | 242,713 | 252,255 | — | (494,968 | ) | — | |||||||||||||||||
Cash flows of loan funding received from the Group’s entities, net of repayments made |
— | (7,167 | ) | 23,247 | 91,794 | (107,874 | ) | — | ||||||||||||||||
Other financing activities |
264,010 | — | 11,891 | (273,906 | ) | — | 1,995 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net cash provided by/(used in) financing activities |
264,010 | 235,546 | 287,393 | (182,112 | ) | (602,842 | ) | 1,995 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
• | Self-operated online sales platform. Our self-operated online sales platform can be accessed by users through Boqii Mall, our mobile app and Weixin/WeChat mini-programs. We sell both branded products and private label products through our online sales platforms. We acquire branded products from our branded partners and private label products from our manufacturing partners before we sell them to our customers. We typically recognize the sales income as our revenue and product procurement costs as our cost of revenue. |
• | Flagship stores on third-party e-commerce platforms. We also sell branded products and private label products on our flagship stores on third-party e-commerce platforms, including Tmall, JD.com and Pinduoduo. We typically pay annual fees to these third-party platforms and account for such annual fees as sales and marketing expenses. |
• | Offline distribution network. We supply branded products and private label products, mostly in bulk, to physical pet stores and pet hospitals at discounted prices. |
• | Membership programs. To cultivate customer stickiness, we offer prepaid membership to users of Boqii Mall. Our prepaid membership card, Magic Black Card, requires a deposit of at least RMB500, which can be used for future purchases on Boqii Mall. We do not recognize the deposit payment as revenue, and instead we recognize revenue only upon successful sales to our customers. |
• | Online marketing and information services. We provide online marketing and information services to pet product brand owners, including helping them place advertisements on our online platforms and third-party platforms and organize marketing campaigns to promote their products and brands. We recognize revenue for provision of online marketing and information services over the service period pursuant to our service contracts with the brand owners. For the fiscal years ended March 31, 2020, 2021 and 2022, we generated a revenue of RMB2.7 million, RMB7.8 million and RMB49.1 (US$7.7 million) from provision of online marketing and information services. |
• | Content offerings. We provide users with informative, fun and interactive content. While our content offerings are free of charge, they provide us with a multitude of monetization opportunities. We engage KOLs to recommend products to our users, and integrate our curated content with relevant products to guide users along their shopping journey. Specifically, we place links to products on Boqii Mall within content to capture purchase impulse and meet user demands, delivering a seamless user experience. |
• | SaaS solution. We have introduced our proprietary SaaS solution, which provides inventory management, membership management, price information and other services, to offline stores. We currently provide the SaaS solution to pet stores for free. Our free SaaS solution serves as our initial contact with physical pet stores and we expect that it will open up more business opportunities with these stores. |
For the fiscal year ended March 31, |
||||||||||||||||||||||||||||
2020 |
2021 |
2022 |
||||||||||||||||||||||||||
RMB |
% |
RMB |
% |
RMB |
US$ |
% |
||||||||||||||||||||||
(in millions, except for percentages) |
||||||||||||||||||||||||||||
GMV generated from sales of branded products |
1,191.0 | 76.4 | 2,074.4 | 85.2 | 2,490.8 | 392.9 | 85.7 | |||||||||||||||||||||
GMV generated from sales of our private label products |
367.0 | 23.6 | 360.8 | 14.8 | 416.4 | 65.7 | 14.3 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total |
1,558.0 |
100.0 |
2,435.2 |
100.0 |
2,907.2 |
458.6 |
100.0 |
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the fiscal year ended March 31, |
||||||||||||||||||||||||||||
2020 |
2021 |
2022 |
||||||||||||||||||||||||||
RMB |
% |
RMB |
% |
RMB |
US$ |
% |
||||||||||||||||||||||
(in millions, except for percentages) |
||||||||||||||||||||||||||||
GMV generated from sales on Boqii Mall |
552.3 | 35.4 | 1,048.5 | 43.1 | 1,242.7 | 196.0 | 42.7 | |||||||||||||||||||||
GMV generated from our sales on third-party e-commerce platforms |
1,005.7 | 64.6 | 1,386.7 | 56.9 | 1,664.5 | 262.6 | 57.3 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total |
1,558.0 |
100.0 |
2,435.2 |
100.0 |
2,907.2 |
458.6 |
100.0 |
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the fiscal year ended March 31, |
||||||||||||||||||||||||||||
2020 |
2021 |
2022 |
||||||||||||||||||||||||||
RMB |
% |
RMB |
% |
RMB |
US$ |
% |
||||||||||||||||||||||
(in thousands, except for percentages) |
||||||||||||||||||||||||||||
Net revenues generated from sales of branded products |
620,391 | 80.8 | 851,915 | 84.9 | 962,215 | 151,786 | 84.6 | |||||||||||||||||||||
Net revenues generated from sales of our private label products |
147,105 | 19.2 | 151,262 | 15.1 | 175,114 | 27,624 | 15.4 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total |
767,496 |
100.0 |
1,003,197 |
100.0 |
1,137,329 |
179,409 |
100.0 |
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the fiscal year ended March 31, |
||||||||||||||||||||||||||||
2020 |
2021 |
2022 |
||||||||||||||||||||||||||
RMB |
% |
RMB |
% |
RMB |
US$ |
% |
||||||||||||||||||||||
(in thousands, except for percentages) |
||||||||||||||||||||||||||||
Net revenues generated from sales on Boqii Mall |
239,879 | 31.3 | 385,627 | 38.4 | 433,573 | 68,394 | 38.1 | |||||||||||||||||||||
Net revenues generated from our sales on third-party e-commerce platforms |
527,617 | 68.7 | 617,570 | 61.6 | 703,756 | 111,015 | 61.9 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total |
767,496 |
100.0 |
1,003,197 |
100.0 |
1,137,329 |
179,409 |
100.0 |
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
• | Delivery and acceptance. Our brand partners are responsible for delivering products to our warehouses, and the products delivered shall conform, in form and substance, to the samples we have accepted. |
• | Quality. The products shall satisfy all applicable quality requirements under relevant laws and regulations, industry standards and our quality standards specified in the agreements. We may reject or return any substandard products. |
• | Purchase commitment. A few brand partners specify minimum purchase requirements in our supply agreements. |
• | Distribution model. Distribution model is the most common inventory model in our operations. Under this model, we purchase products from our brand partners before selling them to customers and take inventory. |
• | Consignment model. We initially partnered with some emerging brand partners, using a consignment model where ownership of the products remained with such brand partners until the products were sold. We believed this model allowed us to minimize inventory and working capital risks. In early 2019, we started to substantially reduce product sales through consignment model as we strategically reduced the sales volume of certain long-tail, less popular products offered by emerging brand partners. |
• | Drop shipping model. Only a few of our manufacturers have chosen drop shipping model. Under this model, we take inventory although our manufacturers ship the products directly to the customers under this model. |
• | Prepaid membership. Prepaid membership is only available to users of Boqii Mall. Our prepaid membership card, Magic Black Card, requires a deposit of at least RMB500, which can be used for purchases on Boqii Mall. Our Magic Black Card holders receive discounts on all purchases made on Boqii Mall, access to limited-time offers, birthday coupons, free shipping twice a month, VIP customer service and other value-added services. |
• | Free membership. Free membership is only available to users of our flagship stores on Tmall, JD.com and Pinduoduo. Users earn points for visiting, making purchases or drawing lotteries on our flagship stores, and points can be then used for deducting the order amounts in future purchases on these stores. Free members enjoy discount offers at our flagship stores from time to time and one-to-one |
License |
Entity Holding the License |
Type of the Entity |
Regulatory Authority | |||
ICP License | Guangcheng Technology | VIE | Shanghai Communication Administration | |||
Veterinary Drug Operation Permit | Guangcheng Technology | VIE | Shanghai Pudong Agricultural Committee | |||
Veterinary Drug Operation Permit | Shanghai Xincheng | WFOE | Shanghai Pudong Agricultural Committee | |||
Veterinary Drug Operation Permit | NanJing Xiangxin Trade Co., Limited | Subsidiary of VIE | Nanjing Yuhuatai District Agricultural Bureau | |||
Veterinary Drug Operation Permit | Guangcheng Technology Wuhu Branch | Branch of VIE | Wuhu Economic Technology Development District Social Affair Bureau | |||
Veterinary Drug Operation Permit | Renchuang (Tianjing) Warehousing Service Co., Limited | Subsidiary of VIE | Tianjing Wuqing District Administrative Approval Bureau | |||
Veterinary Drug Operation Permit | Nanjing Cuida Biotechnology Co., Limited | Subsidiary of VIE | Nanjing Agricultural Committee | |||
Veterinary Drug Operation Permit | Suzhou Taicheng | VIE | Suzhou Agriculture and Country Bureau | |||
Veterinary Drug Operation Permit | Nanjing Xingmu | VIE | Nanjing Yuhua District Agricultural Bureau | |||
Veterinary Drug Operation Permit | Taizhou Xinmu Biotechnology Co., Limited | Subsidiary of VIE | Taizhou Hailing District Agriculture and Country Bureau |
Equity interest | ||
Contractual arrangements, including the exclusive technical consulting and service agreement, intellectual property license agreement, equity pledge agreement, exclusive call option agreement, shareholders’ voting rights proxy agreement and loan agreement. See “—Contractual Arrangements with the VIEs and their Respective Shareholders.” |
• | the ownership structures of the VIEs do not and will not contravene any PRC laws or regulations currently in effect; and |
• | the agreements under the contractual arrangements among Shanghai Xincheng, Shanghai Guangcheng and their respective shareholders, among Xingmu WFOE, Nanjing Xingmu and their respective shareholders, as well as among Shanghai Xincheng, Suzhou Taicheng and their respective shareholders governed by PRC laws are valid and binding upon each party to such agreements and enforceable against each party thereto in accordance with their terms and applicable PRC laws and regulations currently in effect. |
• | China’s overall economic growth, level of urbanization and level of per capita disposable income; |
• | China’s demographic shift in terms of rising numbers of no-kid families and aging population; |
• | Development of China’s online retail market, such as the growing number of online shoppers, improved logistics infrastructure and increasing adoption of mobile payment; |
• | Seasonality of China’s online retail market with increasing sales during the fourth quarter of each year; |
• | Growing population of pets and pet parents and demand for quality pet products and services; |
• | Increase in pet parents’ expenditure on pets, pet products and pet services; and |
• | Market competition. |
For the fiscal year ended March 31, |
||||||||||||||||||||||||||||
2020 |
2021 |
2022 |
||||||||||||||||||||||||||
RMB |
% |
RMB |
% |
RMB |
US$ |
% |
||||||||||||||||||||||
(in thousands, except for share and per share data) |
||||||||||||||||||||||||||||
Summary Consolidated Statements of Operations: |
||||||||||||||||||||||||||||
Net revenues: |
||||||||||||||||||||||||||||
Product sales |
767,496 | 99.6 | 1,003,197 | 99.2 | 1,137,329 | 179,409 | 95.9 | |||||||||||||||||||||
Online marketing and information services and other revenue |
2,741 | 0.4 | 7,788 | 0.8 | 49,100 | 7,745 | 4.1 | |||||||||||||||||||||
Total net revenues |
770,237 | 100.0 | 1,010,985 | 100.0 | 1,186,429 | 187,154 | 100.0 | |||||||||||||||||||||
Total cost of revenues |
(611,470 | ) | (79.4 | ) | (823,686 | ) | (81.5 | ) | (943,698 | ) | (148,865 | ) | (79.5 | ) | ||||||||||||||
Gross profit |
158,767 | 20.6 | 187,299 | 18.5 | 242,731 | 38,289 | 20.5 | |||||||||||||||||||||
Operating expenses: |
||||||||||||||||||||||||||||
Fulfillment expenses |
(115,887 | ) | (15.0 | ) | (120,188 | ) | (11.9 | ) | (134,026 | ) | (21,142 | ) | (11.3 | ) | ||||||||||||||
Sales and marketing expenses |
(128,387 | ) | (16.7 | ) | (160,201 | ) | (15.8 | ) | (170,986 | ) | (26,972 | ) | (14.4 | ) | ||||||||||||||
General and administrative expenses |
(54,277 | ) | (7.0 | ) | (113,972 | ) | (11.3 | ) | (76,248 | ) | (12,028 | ) | (6.4 | ) | ||||||||||||||
Other income, net |
2,398 | 0.3 | 1,067 | 0.1 | 280 | 44 | 0.0 | |||||||||||||||||||||
Loss from operations |
(137,386 | ) | (17.8 | ) | (205,995 | ) | (20.4 | ) | (138,249 | ) | (21,809 | ) | (11.7 | ) | ||||||||||||||
Interest income |
400 | 0.1 | 17,553 | 1.7 | 15,477 | 2,441 | 1.3 | |||||||||||||||||||||
Interest expense |
(59,268 | ) | (7.7 | ) | (27,650 | ) | (2.7 | ) | (20,884 | ) | (3,294 | ) | (1.8 | ) | ||||||||||||||
Other gains (losses), net |
6,984 | 0.9 | 11,332 | 1.1 | 6,020 | 950 | 0.5 | |||||||||||||||||||||
Fair value change of derivative liabilities |
13,345 | 1.7 | 11,369 | 1.1 | 2,824 | 445 | 0.2 | |||||||||||||||||||||
Loss before income tax expenses |
(175,925 | ) | (22.8 | ) | (193,391 | ) | (19.1 | ) | (134,812 | ) | (21,267 | ) | (11.4 | ) | ||||||||||||||
Income tax expenses |
512 | 0.1 | 871 | 0.1 | 1,571 | 248 | 0.1 | |||||||||||||||||||||
Share of results of equity investee |
(520 | ) | (0.1 | ) | (696 | ) | (0.1 | ) | 418 | 65 | 0.0 | |||||||||||||||||
Net loss |
(175,933 | ) | (22.8 | ) | (193,216 | ) | (19.1 | ) | (132,823 | ) | (20,954 | ) | (11.2 | ) | ||||||||||||||
Less: Net income attributable to the noncontrolling interest shareholders |
3,091 | 0.4 | 1,228 | 0.1 | (4,433 | ) | (699 | ) | (0.4 | ) | ||||||||||||||||||
Net loss attributable to Boqii Holding Limited |
(179,024 | ) | (23.2 | ) | (194,444 | ) | (19.2 | ) | (128,390 | ) | (20,255 | ) | (10.8 | ) | ||||||||||||||
Accretion on the convertible redeemable preferred shares to redemption value |
(204,796 | ) | (26.6 | ) | 120,873 | 12.0 | — | — | — | |||||||||||||||||||
Accretion on redeemable noncontrolling interests to redemption value |
— | — | (138 | ) | (0.0 | ) | (575 | ) | (91 | ) | 0.0 | |||||||||||||||||
Deemed dividend to preferred shareholders |
(1,142 | ) | (0.1 | ) | (12,547 | ) | (1.2 | ) | — | — | — | |||||||||||||||||
Net loss attributable to Boqii Holding Limited’s ordinary shareholders |
(384,962 | ) | (50.0 | ) | (86,256 | ) | (8.5 | ) | (128,965 | ) | (20,346 | ) | (10.9 | ) | ||||||||||||||
Net loss per share attributable to Boqii Holding Limited’s ordinary shareholders |
||||||||||||||||||||||||||||
Basic |
(17.31 | ) | (1.29 | ) | (1.90 | ) | (0.30 | ) | ||||||||||||||||||||
Diluted |
(17.31 | ) | (1.29 | ) | (1.90 | ) | (0.30 | ) | ||||||||||||||||||||
Weighted average number of ordinary shares |
||||||||||||||||||||||||||||
Basic |
22,238,454 | 66,953,610 | 68,006,172 | 68,006,172 | ||||||||||||||||||||||||
Diluted |
22,238,454 | 66,953,610 | 68,006,172 | 68,006,172 |
For the Fiscal Year Ended March 31, |
||||||||||||||||||||||||||||
2020 |
2021 |
2022 |
||||||||||||||||||||||||||
RMB |
% |
RMB |
% |
RMB |
US$ |
% |
||||||||||||||||||||||
(in thousands, except for percentages) |
||||||||||||||||||||||||||||
(unaudited) |
||||||||||||||||||||||||||||
Net revenues |
||||||||||||||||||||||||||||
Product sales |
767,496 | 99.6 | 1,003,197 | 99.2 | 1,137,329 | 179,409 | 95.9 | |||||||||||||||||||||
Online marketing and information services and other revenue |
2,741 | 0.4 | 7,788 | 0.8 | 49,100 | 7,745 | 4.1 | |||||||||||||||||||||
Total net revenues |
770,237 |
100.0 |
1,010,985 |
100.0 |
1,186,429 |
187,154 |
100.0 |
For the Fiscal Year Ended March 31, |
||||||||||||||||||||||||||||||||||||||||
2020 |
2021 |
2022 |
||||||||||||||||||||||||||||||||||||||
RMB |
% of total operating expenses |
% of total revenue |
RMB |
% of total operating expenses |
% of total revenue |
RMB |
US$ |
% of total operating expenses |
% of total revenue |
|||||||||||||||||||||||||||||||
Operating expenses: |
||||||||||||||||||||||||||||||||||||||||
Fulfillment expenses |
115,887 | 38.8 | 15.0 | 120,188 | 30.5 | 11.9 | 134,026 | 21,142 | 35.2 | 11.3 | ||||||||||||||||||||||||||||||
Sales and marketing expenses |
128,387 | 43.0 | 16.7 | 160,201 | 40.6 | 15.8 | 170,986 | 26,972 | 44.8 | 14.4 | ||||||||||||||||||||||||||||||
General and administrative expenses |
54,277 | 18.2 | 7.0 | 113,972 | 28.9 | 11.3 | 76,248 | 12,028 | 20.0 | 6.4 | ||||||||||||||||||||||||||||||
Total Operating expenses |
298,551 |
100.0 |
38.7 |
394,361 |
100.0 |
39.0 |
381,260 |
60,142 |
100.0 |
32.1 |
For the fiscal year ended March 31, |
||||||||||||||||||||||||||||
2020 |
2021 |
2022 |
||||||||||||||||||||||||||
RMB |
% |
RMB |
% |
RMB |
US$ |
% |
||||||||||||||||||||||
(in thousands, except for share and per share data) |
||||||||||||||||||||||||||||
Summary Consolidated Statements of Operations: |
||||||||||||||||||||||||||||
Net revenues: |
||||||||||||||||||||||||||||
Product sales |
767,496 | 99.6 | 1,003,197 | 99.2 | 1,137,329 | 179,409 | 95.9 | |||||||||||||||||||||
Online marketing and information services and other revenue |
2,741 | 0.4 | 7,788 | 0.8 | 49,100 | 7,745 | 4.1 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total net revenues |
770,237 | 100.0 | 1,010,985 | 100.0 | 1,186,429 | 187,154 | 100.0 | |||||||||||||||||||||
Total cost of revenues |
(611,470 | ) | (79.4 | ) | (823,686 | ) | (81.5 | ) | (943,698 | ) | (148,865 | ) | (79.5 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Gross profit |
158,767 | 20.6 | 187,299 | 18.5 | 242,731 | 38,289 | 20.5 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Operating expenses: |
||||||||||||||||||||||||||||
Fulfillment expenses |
(115,887 | ) | (15.0 | ) | (120,188 | ) | (11.9 | ) | (134,026 | ) | (21,142 | ) | (11.3 | ) | ||||||||||||||
Sales and marketing expenses |
(128,387 | ) | (16.7 | ) | (160,201 | ) | (15.8 | ) | (170,986 | ) | (26,972 | ) | (14.4 | ) | ||||||||||||||
General and administrative expenses |
(54,277 | ) | (7.0 | ) | (113,972 | ) | (11.3 | ) | (76,248 | ) | (12,028 | ) | (6.4 | ) | ||||||||||||||
Other income, net |
2,398 | 0.3 | 1,067 | 0.1 | 280 | 44 | 0.0 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Loss from operations |
(137,386 | ) | (17.8 | ) | (205,995 | ) | (20.4 | ) | (138,249 | ) | (21,809 | ) | (11.7 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Interest income |
400 | 0.1 | 17,553 | 1.7 | 15,477 | 2,441 | 1.3 | |||||||||||||||||||||
Interest expense |
(59,268 | ) | (7.7 | ) | (27,650 | ) | (2.7 | ) | (20,884 | ) | (3,294 | ) | (1.8 | ) | ||||||||||||||
Other gains (losses), net |
6,984 | 0.9 | 11,332 | 1.1 | 6,020 | 950 | 0.5 | |||||||||||||||||||||
Fair value change of derivative liabilities |
13,345 | 1.7 | 11,369 | 1.1 | 2,824 | 445 | 0.2 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Loss before income tax expenses |
(175,925 | ) | (22.8 | ) | (193,391 | ) | (19.1 | ) | (134,812 | ) | (21,267 | ) | (11.4 | ) | ||||||||||||||
Income tax expenses |
512 | 0.1 | 871 | 0.1 | 1,571 | 248 | 0.1 | |||||||||||||||||||||
Share of result of equity investee |
(520 | ) | (0.1 | ) | (696 | ) | (0.1 | ) | 418 | 65 | 0.0 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Net loss |
(175,933 | ) | (22.8 | ) | (193,216 | ) | (19.1 | ) | (132,823 | ) | (20,954 | ) | (11.2 | ) | ||||||||||||||
Less: Net income attributable to the noncontrolling interest shareholders |
3,091 | 0.4 | 1,228 | 0.1 | (4,433 | ) | (699 | ) | (0.4 | ) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Net loss attributable to Boqii Holding Limited |
(179,024 | ) | (23.2 | ) | (194,444 | ) | (19.2 | ) | (128,390 | ) | (20,255 | ) | (10.8 | ) | ||||||||||||||
Accretion on the preferred shares to redemption value |
(204,796 | ) | (26.6 | ) | 120,873 | 12.0 | — | — | — | |||||||||||||||||||
Accretion on redeemable noncontrolling interests to redemption value |
— | — | (138 | ) | (0.0 | ) | (575 | ) | (91 | ) | (0.0 | ) | ||||||||||||||||
Deemed dividend to preferred shareholders |
(1,142 | ) | (0.1 | ) | (12,547 | ) | (1.2 | ) | — | — | — | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Net loss attributable to Boqii Holding Limited’s ordinary shareholders |
(384,962 | ) | (50.0 | ) | (86,256 | ) | (8.5 | ) | (128,965 | ) | (20,346 | ) | (10.9 | ) |
For the fiscal year ended March 31, |
||||||||||||||||
2020 |
2021 |
2022 |
||||||||||||||
RMB |
RMB |
RMB |
US$ |
|||||||||||||
(in thousands) |
||||||||||||||||
Net cash flows used in operating activities |
(165,912 | ) | (247,486 | ) | (147,504 | ) | (23,271 | ) | ||||||||
Net cash flows generated from/(used in) investing activities |
(75,056 | ) | (184,417 | ) | 21,147 | 3,337 | ||||||||||
Net cash flows generated from financing activities |
295,032 | 648,491 | 1,995 | 315 | ||||||||||||
Net increase/(decrease) in cash and cash equivalents |
54,064 | 216,588 | (124,362 | ) | (19,619 | ) | ||||||||||
Cash and cash equivalents at beginning of the year |
27,217 | 88,352 | 292,237 | 46,099 | ||||||||||||
Effects of foreign exchange rate changes on cash and cash equivalents |
7,071 | (12,703 | ) | (5,020 | ) | (790 | ) | |||||||||
Cash and cash equivalents at the end of the period |
88,352 | 292,237 | 162,855 | 25,690 |
Directors and Executive Officers |
Age |
Position/Title | ||
Hao (Louis) Liang | 43 | Director, Chairman and Chief Executive Officer | ||
Yingzhi (Lisa) Tang | 42 | Director, co-Chief Executive Officer and Chief Financial Officer | ||
Noorsurainah Tengah | 40 | Independent Director | ||
Dong Li | 45 | Independent Director | ||
Leaf Hua Li | 45 | Independent Director | ||
Chao Guo | 38 | Senior Vice President | ||
Kai Fang | 44 | Senior Vice President |
Ordinary Shares Underlying Options Granted |
Exercise Price (US$/Share) |
Date of Grant |
Date of Expiration | |||||||||
Hao (Louis) Liang |
* | 0.10 to 4.13 | various dates from September 27, 2012 to December 29, 2021 |
various dates from September 26, 2022 to December 28, 2031 | ||||||||
Yingzhi (Lisa) Tang |
* | 0.10 to 4.13 | various dates from September 27, 2012 to October 10, 2020 |
various dates from September 26, 2022 to October 9, 2030 | ||||||||
Noorsurainah Tengah |
— | — | — | — | ||||||||
Dong Li |
— | — | — | — | ||||||||
Leaf Hua Li |
— | — | — | — | ||||||||
Chao Guo |
* | 4.13 | May 17, 2021 | May 16, 2031 | ||||||||
|
|
|
|
|
| |||||||
All directors and executive officers as a group |
1,220,817 | 0.10 to 4.13 | various dates from September 27, 2012 to December 29, 2021 |
various dates from September 26, 2022 to December 28, 2031 |
* | Less than 1% of our total outstanding shares. |
• | selecting the independent registered public accounting firm and preapproving all auditing and nonauditing services permitted to be performed by the independent registered public accounting firm; |
• | reviewing with the independent registered public accounting firm any audit problems or difficulties and management’s response; |
• | reviewing and approving all proposed related party transactions; |
• | discussing the annual audited financial statements with management and the independent registered public accounting firm; |
• | reviewing major issues as to the adequacy of our internal controls and any special audit steps adopted in light of material control deficiencies; |
• | annually reviewing and reassessing the adequacy of our audit committee charter; |
• | meeting separately and periodically with management and the independent registered public accounting firm; and |
• | reporting regularly to the board of directors. |
• | reviewing and approving the compensation for our executive officers; |
• | reviewing and evaluating periodically the management succession plan in consultation with the chief executive officer; |
• | reviewing any incentive compensation or equity plans, programs or similar arrangements; |
• | selecting compensation consultant, legal counsel or other adviser only after taking into consideration of all factors relevant to that person’s independence from management; and |
• | reporting periodically to the board of directors. |
• | recommending nominees to the board for membership on the board and its committees pursuant to the terms of the Post-IPO MAA effective upon the completion of our initial public offering; |
• | leading and overseeing self-evaluation of the board at least annually to determine whether it and its committees are functioning effectively; |
• | recommending criteria for the selection of candidates to the board of directors and its committees; |
• | selecting and recommending to the board the names of directors to serve as members of the audit committee and the compensation committee, as well as of the nominating and corporate governance committee itself; |
• | developing and recommending to the board of directors the code of business conduct and ethics; and |
• | overseeing and setting compensation for our directors. |
Function |
Number of employees |
|||
Fulfillment |
27 | |||
Sales and marketing |
253 | |||
General and administrative |
137 | |||
|
|
|||
Total |
417 |
|||
|
|
• | each of our directors and executive officers; and |
• | each person known to us to beneficially own more than 5% of our ordinary shares. |
Ordinary Shares Beneficially Owned as of March 31, 2022 |
||||||||||||||||||||||||||||
Class A ordinary shares |
Class B ordinary shares |
Total ordinary shares on an as-converted basis |
Percentage of aggregate voting power*** |
|||||||||||||||||||||||||
Number |
% |
Number |
% |
Number |
% |
|||||||||||||||||||||||
Directors and Executive Officers:**† |
||||||||||||||||||||||||||||
Hao (Louis) Liang (1) |
791,331 | 1.4 | 8,314,160 | 63.8 | 9,105,491 | 13.2 | 52.8 | |||||||||||||||||||||
Yingzhi (Lisa) Tang (2) |
379,486 | 0.7 | 4,345,475 | 33.3 | 4,724,961 | 6.9 | 27.6 | |||||||||||||||||||||
Noorsurainah Tengah |
— | — | — | — | — | — | — | |||||||||||||||||||||
Dong Li |
— | — | — | — | — | — | — | |||||||||||||||||||||
Leaf Hua Li |
— | — | — | — | — | — | — | |||||||||||||||||||||
Chao Guo |
* | * | — | — | * | * | * | |||||||||||||||||||||
Kai Fang |
* | * | — | — | * | * | * | |||||||||||||||||||||
All directors and executive officers as a group |
1,220,817 | 2.2 | 12,659,635 | 97.1 | 13,880,452 | 20.2 | 80.4 | |||||||||||||||||||||
Principal Shareholders: |
||||||||||||||||||||||||||||
Merchant Tycoon Limited (1)(2)(3) |
— | — | 13,037,729 | 100.0 | 13,037,729 | 19.0 | 82.4 | |||||||||||||||||||||
CMB (4) |
9,723,259 | 17.5 | — | — | 9,723,259 | 14.1 | 3.1 | |||||||||||||||||||||
CW PETS Limited (5) |
6,197,747 | 11.1 | — | — | 6,197,747 | 9.0 | 2.0 | |||||||||||||||||||||
Apsaras Legend Limited (6) |
5,112,641 | 9.2 | — | — | 5,112,641 | 7.4 | 1.6 | |||||||||||||||||||||
Raumier Limited (7) |
4,842,587 | 8.7 | — | — | 4,842,587 | 7.0 | 1.5 | |||||||||||||||||||||
Chong Li’s Entities (8) |
4,841,138 | 8.7 | — | — | 4,841,138 | 7.0 | 1.5 |
* | Less than 1% of our total outstanding shares. |
** | For each person and group included in this table, percentage ownership is calculated by dividing the number of shares beneficially owned by such person or group by the sum of (i) 68,747,320, being the number of ordinary shares on an as-converted basis issued and outstanding as of the date of this annual report, and (ii) the number of ordinary shares underlying share options held by such person or group that are exercisable within 60 days after the date of this annual report. |
*** | For each person and group included in this column, percentage of voting power is calculated by dividing the voting power beneficially owned by such person or group by the voting power of all of our ordinary shares as a single class. Each holder of Class A ordinary shares is entitled to one vote per share and each holder of our Class B ordinary shares is entitled to 20 votes per share on all matters submitted to them for a vote. Our Class A ordinary shares and Class B ordinary shares vote together as a single class on all matters submitted to a vote of our shareholders, except as may otherwise be required by law. Our Class B ordinary shares are convertible at any time by the holder thereof into Class A ordinary shares on a one-for-one |
† |
The business address of our executive officers is Building 9, No. 388, Shengrong Road, Pudong New District, Shanghai 201210, People’s Republic of China. |
(1) | Represents an aggregate of 9,105,491 as-converted ordinary shares, consisting of (i) 8,314,160 as-converted Class B ordinary shares held by Merchant Tycoon Limited, a limited liability company incorporated under the laws of the British Virgin Islands; and (ii) 791,331 Class A ordinary shares underlying share options held by Hao (Louis) Liang that are exercisable within 60 days after the date of this annual report. Hao (Louis) Liang holds 63.77% of equity interest in Merchant Tycoon Limited. The registered address of Merchant Tycoon Limited is Trinity Chambers, PO Box 4301, Road Town, Tortola, British Virgin Islands. Based on the terms of governing documents of Merchant Tycoon Limited, Hao (Louis) Liang disclaims beneficial ownership of the ordinary shares beneficially owned by Yingzhi (Lisa) Tang and Di (Jackie) Chen through their respective shareholding in Merchant Tycoon Limited. |
(2) | Represents an aggregate of 4,724,961 as-converted ordinary shares, consisting of (i) 4,345,475 as-converted Class B ordinary shares held by Merchant Tycoon Limited, a limited liability company incorporated under the laws of the British Virgin Islands; and (ii) 379,486 Class A ordinary shares underlying share options held by Yingzhi (Lisa) Tang that are exercisable within 60 days after the date of this annual report. Yingzhi (Lisa) Tang holds 33.33% of equity interest in Merchant Tycoon Limited. The registered address of Merchant Tycoon Limited is Trinity Chambers, PO Box 4301, Road Town, Tortola, British Virgin Islands. Based on the terms of governing documents of Merchant Tycoon Limited, Yingzhi (Lisa) Tang disclaims beneficial ownership of the ordinary shares beneficially owned by Hao (Louis) Liang and Di (Jackie) Chen through their respective shareholding in Merchant Tycoon Limited. |
(3) | Represents an aggregate of 664,580 as-converted ordinary shares, consisting of (i) 378,094 as-converted Class B ordinary shares held by Merchant Tycoon Limited, a limited liability company incorporated under the laws of the British Virgin Islands; and (ii) 286,486 Class A ordinary shares underlying share options held by Di (Jackie) Chen that are exercisable within 60 days after the date of this annual report. Di (Jackie) Chen holds 2.9% of equity interest in Merchant Tycoon Limited. The registered address of Merchant Tycoon Limited is Trinity Chambers, PO Box 4301, Road Town, Tortola, British Virgin Islands. Based on the terms of governing documents of Merchant Tycoon Limited, Di (Jackie) Chen disclaims beneficial ownership of the ordinary shares beneficially owned by Hao (Louis) Liang and Yingzhi (Lisa) Tang through their respective shareholding in Merchant Tycoon Limited. |
(4) | Representing an aggregate of 9,723,259 as-converted Class A ordinary shares consisting of (i) 3,085,675 as-converted Class A ordinary shares held by CMBI Private Equity Series SPC (acting for and on behalf of Internet Retail Fund I SP), a segregated portfolio company incorporated under the laws of the Cayman Islands, which is ultimately controlled by China Merchants Bank Co., Limited (HKG: 3968). The registered address of CMBI Private Equity Series SPC is 4th Floor, Harbour Place, 103 South Church Street, P.O. Box 10240, Grand Cayman KYI-1002, Cayman Islands; and (ii) 6,637,584 as-converted Class A ordinary shares held by Shanghai Qiji Technology LLP., a limited liability company incorporated under the laws of the People’s Republic of China, which is ultimately controlled by China Merchants Bank Co., Limited (HKG: 3968). The registered address of Shanghai Qiji Technology LLP. is 2A, No. 1200, Pudong Avenue, Pilot Free Trade Zone, Shanghai, People’s Republic of China. |
(5) | Represents 6,197,747 as-converted Class A ordinary shares held by CW PETS Limited, a limited liability company incorporated under the laws of the British Virgin Islands, in which Chengwei Capital HK Limited holds 100.0% equity interest and ultimately controlled by Eric Li. The registered address of CW PETS Limited is P.O. Box 4301, Road Town, Tortola, British Virgin Islands. |
(6) | Represents 5,112,641 as-converted Class A ordinary shares held by Apsaras Legend Limited, a limited liability company incorporated under the laws of the British Virgin Islands, ultimately controlled by Fengjin Jiang. |
(7) | Represents 4,842,587 as-converted Class A ordinary shares held by Raumier Limited, a limited liability company incorporated under the Companies (Jersey) Laws, in which Premier Circle Limited holds 50% equity interest and Second Circle Limited holds 50% equity interest. The registered address of Raumier Limited is 26 New Street, St Helier, Jersey, JE2 3RA. |
(8) | Represents an aggregate of 4,841,138 as-converted Class A ordinary shares, consisting of (i) 4,591,045 as-converted Class A ordinary shares held by Perfect Deal Global Limited, a limited liability company incorporated under the laws of the British Virgin Islands, in which Chong Li holds 100.0% equity interest. The registered address of Superb Origin International Limited is Trinity Chambers, PO Box 4301, Road Town, Tortola, British Virgin Islands; and (ii) 250,093 as-converted Class A ordinary shares held by DL Capital Holding Limited, a limited liability company incorporated under the laws of the British Virgin Islands, in which Chong Li holds 100.0% equity interest. The registered address of DL Capital Holding Limited is Trinity Chambers, P.O. Box 4301, Road Town, Tortola, British Virgin Island. |
Name of related parties |
Relationship with the Company | |
Nanjing Xingmu | An equity investee of the Company before November 1, 2019 | |
Nanjing Animal Pharmaceutical | An equity investee of the Company | |
Wuhan Chunzhijin | An equity investee of the Company | |
Weishi Network | An equity investee of the Company | |
Beijing Petdog | An available-for-sale | |
Shanghai Guangcheng Information Technology (limited partnership) (“Shanghai Guangcheng Information”) | A company with a common director of the Company | |
Yingzhi (Lisa) Tang | Senior management of the Company | |
Di (Jackie) Chen | Senior management of the Company until July, 2021 | |
Ying (Christina) Zhang | Senior management of the Company until February, 2022 | |
Fei Wang | Senior management of the Company until April, 2022 | |
Yan Jiang | Senior management of the Company | |
Lijun Zhou | Senior management of the Company until April, 2022 |
Year ended March 31, 2020 |
Year ended March 31, 2021 |
Year ended March 31, 2022 |
||||||||||||||
RMB |
RMB |
RMB |
US$ |
|||||||||||||
(in thousands) |
||||||||||||||||
Sales of goods |
||||||||||||||||
Beijing Petdog |
2,316 | — | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Online marketing and information services |
||||||||||||||||
Beijing Petdog |
315 | 410 | — | — | ||||||||||||
Weishi Network |
— | — | 19 | 3 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
315 | 410 | 19 | 3 | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Purchase of merchandise |
||||||||||||||||
Nanjing Xingmu |
751 | — | — | — | ||||||||||||
Weishi Network |
— | — | 1,582 | 250 | ||||||||||||
Nanjing Animal Pharmaceutical |
45 | 250 | 1,020 | 161 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
796 | 250 | 2,602 | 410 | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Loans granted to related parties |
||||||||||||||||
Shanghai Guangcheng Information (a) |
— | — | 33,395 | 5,268 | ||||||||||||
Wuhan Chunzhijin (b) |
— | 5,690 | 2,600 | 410 | ||||||||||||
Yingzhi (Lisa) Tang |
— | — | 1,750 | 276 | ||||||||||||
Lijun Zhou |
— | — | 300 | 47 | ||||||||||||
Nanjing Animal Pharmaceutical |
1,000 | 500 | — | — | ||||||||||||
Yan Jiang |
— | 200 | 70 | 11 | ||||||||||||
Ying (Christina) Zhang |
152 | — | — | — | ||||||||||||
Di (Jackie) Chen |
785 | — | — | — | ||||||||||||
Fei Wang (c) |
— | 500 | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
1,937 | 6,890 | 38,115 | 6,012 | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Staff advances |
||||||||||||||||
Di (Jackie) Chen |
6 | — | — | — | ||||||||||||
Yingzhi (Lisa) Tang |
— | 10 | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
6 | 10 | — | — | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Advances provided to related parties |
||||||||||||||||
Nanjing Animal Pharmaceutical |
— | 2,073 | — | — | ||||||||||||
Wuhan Chunzhijin |
3.350 | — | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
3,350 | 2,073 | — | — | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Loans granted from related parties |
||||||||||||||||
Shanghai Guangcheng Information (d) |
— | — | 9,961 | 1,571 | ||||||||||||
Yingzhi (Lisa) Tang (e) |
1,450 | — | — | — | ||||||||||||
Yan Jiang (f) |
9,000 | — | — | — | ||||||||||||
Di (Jackie) Chen (g) |
1,250 | — | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
11,700 | — | 9,961 | 1,571 | |||||||||||||
|
|
|
|
|
|
|
|
As of March 31, 2020 |
As of March 31, 2021 |
As of March 31, 2022 |
||||||||||||||
RMB |
RMB |
RMB |
US$ |
|||||||||||||
Trade receivables from related parties |
||||||||||||||||
Beijing Petdog |
1,564 | — | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Prepayments to related parties |
||||||||||||||||
Nanjing Animal Pharmaceutical |
— | 2,023 | 1,650 | 260 | ||||||||||||
Weishi Network |
— | — | 1,582 | 250 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
— | 2,023 | 3,232 | 510 | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Other receivables from related parties |
||||||||||||||||
Wuhan Chunzhijin |
2,481 | 7,295 | 7,594 | 1,198 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Loans to related parties |
||||||||||||||||
Nanjing Animal Pharmaceutical |
1,000 | 500 | — | — | ||||||||||||
Yingzhi (Lisa) Tang |
— | 10 | — | — | ||||||||||||
Yan Jiang |
— | 200 | 200 | 32 | ||||||||||||
Di (Jackie) Chen (h) |
785 | 785 | — | — | ||||||||||||
Ying (Christina) Zhang |
152 | 152 | — | — | ||||||||||||
Lijun Zhou |
— | — | 200 | 32 | ||||||||||||
Fei Wang (i) |
— | 500 | 500 | 79 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
1,937 | 2,147 | 900 | 142 | |||||||||||||
|
|
|
|
|
|
|
|
As of March 31, 2020 |
As of March 31, 2021 |
As of March 31, 2022 |
||||||||||||||
RMB |
RMB |
RMB |
US$ |
|||||||||||||
Trade payables to related parties |
||||||||||||||||
Nanjing Animal Pharmaceutical |
45 | 874 | 219 | 35 | ||||||||||||
|
|
|
|
|
|
|
|
As of March 31, 2020 |
As of March 31, 2021 |
As of March 31, 2022 |
||||||||||||||
RMB |
RMB |
RMB |
US$ |
|||||||||||||
Advances from related parties |
||||||||||||||||
Beijing Petdog |
— | 36 | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Long-term loan from related parties |
||||||||||||||||
Yingzhi (Lisa) Tang (j) |
2,521 | — | — | — | ||||||||||||
Yan Jiang (k) |
9,000 | — | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
11,521 | — | — | — | |||||||||||||
|
|
|
|
|
|
|
|
(a) | In April 2021, the Company granted Shanghai Guangcheng Information a short-term loan with a total principal amount of RMB33.4 million (equivalent to USD5 million), bearing an interest rate of 3.5% per annum. The loan was fully repaid by March 31, 2022. |
(b) | From April 2020 to January 2021, the Company provided interest free loans to Wuhan Chunzhijin with an aggregate amount of RMB5.7 million, which will be repaid on demand. |
(c) | In January 2021, the Company entered into a one-year loan agreement with Fei Wang, for a principal amount of RMB0.5 million, bearing an interest rate of 4% per annum. This Loan was pledged by 515,000 stock options owned by Fei Wang. |
(d) | In April 2021, the Company obtained a total loan facility up to USD5 million from Shanghai Guangcheng Information. During the year ended March 31, 2022, the Company drew down a total amount of USD1.5 million (equivalent to RMB10.0 million) from the loan facility, with interest bearing at 3.5% per annum. The loan was fully repaid by March 31, 2022. |
(e) | In September 2019, the Company obtained a two-year loan of RMB1.5 million from Yingzhi (Lisa) Tang, bearing an interest rate of 9.0% per annum. The loan was early repaid in December 2020. |
(f) | In September 2019, the Company obtained a two-year loan of RMB9 million from Yan Jiang, bearing an interest rate of 9.0% per annum. The loan was early repaid in December 2020. |
(g) | In October 2019, Di (Jackie) Chen advanced RMB1.25 million to the Company, which was repaid by the Company in the same month. |
(h) | In December 2019, the Company entered into a 12 month interest free loan agreement with, Di (Jackie) Chen, for a principal amount of RMB0.7 million. In December 2020, the loan contract was renewed for another one year. |
(i) | In January 2021, the Company entered into a one-year loan agreement with Fei Wang, for a principal amount of RMB0.5 million, bearing an interest rate of 4% per annum. This Loan was pledged by 515,000 stock options owned by Fei Wang. |
(j) | In July 2018, the Company entered into a forty-month loan agreement with Yingzhi (Lisa) Tang, for a principal amount of US$0.15 million (RMB1.0 million), bearing an interest rate of 6% per annum. The loan was early repaid in January 2021. |
(k) | The balance as of December 31, 2019 represented a two-year loan of RMB9 million due to Yan Jiang, bearing an interest rate of 9.0% per annum. The loan was early repaid in December 2020. |
• | the instrument of transfer is lodged with us, accompanied by the certificate for the ordinary shares to which it relates and such other evidence as our board of directors may reasonably require to show the right of the transferor to make the transfer; |
• | the instrument of transfer is in respect of only one class of shares; |
• | the instrument of transfer is properly stamped, if required; |
• | in the case of a transfer to joint holders, the number of joint holders to whom the ordinary share is to be transferred does not exceed four; and |
• | a fee of such maximum sum as the NYSE may determine to be payable or such lesser sum as our directors may from time to time require is paid to us in respect thereof. |
• | the designation of the series; |
• | the number of shares of the series; |
• | the dividend rights, dividend rates, conversion rights, voting rights; and |
• | the rights and terms of redemption and liquidation preferences. |
• | does not have to file an annual return of its shareholders with the Registrar of Companies; |
• | is not required to open its register of members for inspection; |
• | does not have to hold an annual general meeting; |
• | may obtain an undertaking against the imposition of any future taxation (such undertakings are usually given for 20 years in the first instance); |
• | may register by way of continuation in another jurisdiction and be deregistered in the Cayman Islands; |
• | may register as a limited duration company; and |
• | may register as a segregated portfolio company. |
• | certain financial institutions; |
• | insurance companies; |
• | regulated investment companies; |
• | dealers or traders in securities that use a mark-to-market |
• | persons holding ADSs or Class A ordinary shares as part of a straddle, integrated or similar transaction; |
• | persons whose functional currency for U.S. federal income tax purposes is not the U.S. dollar; |
• | entities classified as partnerships for U.S. federal income tax purposes and their partners; |
• | tax-exempt entities, “individual retirement accounts” or “Roth IRAs”; |
• | persons that acquired ADSs or Class A ordinary shares as compensation; |
• | persons that own or are deemed to own ADSs or Class A ordinary shares representing 10% or more of our voting power or value; or |
• | persons holding ADSs or Class A ordinary shares in connection with a trade or business outside the United States. |
• | a citizen or individual resident of the United States; |
• | a corporation, or other entity taxable as a corporation, created or organized in or under the laws of the United States, any state therein or the District of Columbia; or |
• | an estate or trust the income of which is subject to U.S. federal income taxation regardless of its source. |
As of March 31, 2020 |
As of March 31, 2021 |
As of March 31, 2022 |
||||||||||
Royal Canin China Co., Ltd. |
24 | % | 19 | % | 17 | % |
Persons depositing or withdrawing shares or ADS holders must pay: |
For: | |
$5.00 (or less) per 100 ADSs (or portion of 100 ADSs) | Issuance of ADSs, including issuances resulting from a distribution of shares or rights or other property Cancellation of ADSs for the purpose of withdrawal, including if the deposit agreement terminates | |
$.05 (or less) per ADS | Any cash distribution to ADS holders | |
A fee equivalent to the fee that would be payable if securities distributed to you had been shares and the shares had been deposited for issuance of ADSs | Distribution of securities distributed to holders of deposited securities (including rights) that are distributed by the depositary to ADS holders | |
$.05 (or less) per ADS per calendar year | Depositary services | |
Registration or transfer fees | Transfer and registration of shares on our share register to or from the name of the depositary or its agent when you deposit or withdraw shares | |
Expenses of the depositary | Cable (including SWIFT) and facsimile transmissions (when expressly provided in the deposit agreement) Converting foreign currency to U.S. dollars | |
Taxes and other governmental charges the depositary or the custodian has to pay on any ADSs or shares underlying ADSs, such as stock transfer taxes, stamp duty or withholding taxes | As necessary | |
Any charges incurred by the depositary or its agents for servicing the deposited securities | As necessary |
Fiscal Year Ended March 31, |
||||||||||||||||
2020 |
2021 |
2022 |
||||||||||||||
RMB |
RMB |
RMB |
US$ |
|||||||||||||
(in thousands) |
||||||||||||||||
Audit Fees (1) |
9,800 | 7,800 | 5,300 | 836 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Tax Fees (2) |
— | 40 | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
9,800 | 8,200 | 5,300 | 836 | ||||||||||||
|
|
|
|
|
|
|
|
(1) | Audit Fees |
(2) | Tax Fees |
* | Filed herewith |
** | Furnished herewith |
BOQII HOLDING LIMITED | ||||
By: | /s/ Yingzhi (Lisa) Tang | |||
Name: | Yingzhi (Lisa) Tang | |||
Title: | Director, co-Chief Executive Officer and Chief Financial Officer |
Report of Independent Registered Public Accounting Firm (PCAOB ID: |
F-2 | |
F-3-F-4 | ||
F-5 | ||
F-6-F-9 | ||
F-10-F-11 | ||
F-12-F-67 |
/s/ |
July 27, 2022 |
As of March 31, |
||||||||||||||||
Note |
2021 |
2022 |
||||||||||||||
RMB |
RMB |
US$ (Note 2(f)) |
||||||||||||||
ASSETS |
||||||||||||||||
Current assets: |
||||||||||||||||
Cash and cash equivalents |
5 | |||||||||||||||
Short-term investments |
||||||||||||||||
Accounts receivable, net |
6 | |||||||||||||||
Inventories, net |
7 | |||||||||||||||
Prepayments and other current assets |
8 | |||||||||||||||
Amounts due from related parties |
27 | |||||||||||||||
|
|
|
|
|
|
|||||||||||
Total current assets |
||||||||||||||||
|
|
|
|
|
|
|||||||||||
Non-current assets: |
||||||||||||||||
Property and equipment, net |
9 | |||||||||||||||
Intangible assets |
10 | |||||||||||||||
Operating lease right-of-use |
15 | |||||||||||||||
Long-term investments |
11 | |||||||||||||||
Goodwill |
12 | |||||||||||||||
Other non-current asset |
13 | |||||||||||||||
|
|
|
|
|
|
|||||||||||
Total non-current assets |
||||||||||||||||
|
|
|
|
|
|
|||||||||||
Total assets |
||||||||||||||||
|
|
|
|
|
|
|||||||||||
LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS’ EQUITY |
||||||||||||||||
Current liabilities |
||||||||||||||||
Short-term borrowings (including amounts of the consolidated VIEs and VIEs’ subsidiaries without recourse to the Company of RMB |
22 | |||||||||||||||
Accounts payable (including accounts payable of the consolidated VIEs and VIEs’ subsidiaries without recourse to the Company of RMB Group’s entities of RMB |
||||||||||||||||
Salary and welfare payable (including amounts of the consolidated VIEs and VIEs’ subsidiaries without recourse to the Company of RMB |
||||||||||||||||
Accrued liabilities and other current liabilities (including amounts of the consolidated VIEs and VIEs’ subsidiaries without recourse to the Company of RMB Group’s entities of RMB |
14 | |||||||||||||||
Amounts due to related parties, current (including amounts of the consolidated VIEs and VIEs’ subsidiaries without recourse to the Company of RMB |
27 | |||||||||||||||
Contract liabilities (including amounts of the consolidated VIEs and VIEs’ subsidiaries without recourse to the Company of RMB |
||||||||||||||||
Operating lease liabilities, current (including amounts of the consolidated VIEs and VIEs’ subsidiaries without recourse to the Company of RMB |
15 | |||||||||||||||
Derivative liabilities (including amounts of the consolidated VIEs and VIEs’ subsidiaries without recourse to the Company |
22 | |||||||||||||||
|
|
|
|
|
|
|||||||||||
Total current liabilities |
||||||||||||||||
|
|
|
|
|
|
As of March 31, |
||||||||||||||||
Note |
2021 |
2022 |
||||||||||||||
RMB |
RMB |
US$ (Note 2(f)) |
||||||||||||||
LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS’ EQUITY (CONTINUED) |
|
|||||||||||||||
Non-current liabilities |
||||||||||||||||
Deferred tax liabilities (including amounts of the consolidated VIEs and VIEs’ subsidiaries without recourse to the Company of RMB |
18 | |||||||||||||||
Operating lease liabilities, non-current (including amounts of the consolidated VIEs and VIEs’ subsidiaries without recourse to the Company of RMB |
15 | |||||||||||||||
Long-term borrowings (including amounts of the consolidated VIEs and VIEs’ subsidiaries without recourse to the Company of RMB |
22 | |||||||||||||||
Other debts, non-current (including amounts of the consolidated VIEs and VIEs’ subsidiaries without recourse to the Company of RMB |
22 | |||||||||||||||
|
|
|
|
|
|
|||||||||||
Total non-current liabilities |
||||||||||||||||
|
|
|
|
|
|
|||||||||||
Total liabilities |
||||||||||||||||
|
|
|
|
|
|
|||||||||||
Commitments and contingencies (Note 2 9 ) |
||||||||||||||||
Mezzanine equity: |
||||||||||||||||
Redeemable non-controlling interests |
21 | |||||||||||||||
|
|
|
|
|
|
|||||||||||
Total mezzanine equity |
||||||||||||||||
|
|
|
|
|
|
|||||||||||
Shareholders’ equity: |
||||||||||||||||
Class A ordinary shares (US$ |
19 | |||||||||||||||
Class B ordinary shares (US$ |
19 | |||||||||||||||
Additional paid-in capital |
||||||||||||||||
Statutory reserves |
||||||||||||||||
Accumulated other comprehensive loss |
( |
) | ( |
) | ( |
) | ||||||||||
Accumulated deficit |
( |
) | ( |
) | ( |
) | ||||||||||
Receivable for issuance of ordinary shares |
2 3 |
( |
) | ( |
) | ( |
) | |||||||||
|
|
|
|
|
|
|||||||||||
Total Boqii Holding Limited shareholders’ equity |
||||||||||||||||
|
|
|
|
|
|
|||||||||||
Non-controlling interests |
||||||||||||||||
|
|
|
|
|
|
|||||||||||
Total shareholders’ equity |
||||||||||||||||
|
|
|
|
|
|
|||||||||||
Total liabilities, mezzanine equity and shareholders’ equity |
||||||||||||||||
|
|
|
|
|
|
Year Ended March 31, |
||||||||||||||||||||
Note |
2020 |
2021 |
2022 |
|||||||||||||||||
RMB |
RMB |
RMB |
US$ (Note 2(f)) |
|||||||||||||||||
Net revenues: |
||||||||||||||||||||
Product sales |
||||||||||||||||||||
Online marketing and information services and other revenue |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total revenues |
||||||||||||||||||||
Total cost of revenue |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Gross profit |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Operating expenses: |
||||||||||||||||||||
Fulfillment expenses |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
Sales and marketing expenses |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
General and administrative expenses |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
Other income, net |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Loss from operations |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Interest income |
||||||||||||||||||||
Interest expense |
16 | ( |
) | ( |
) | ( |
) | ( |
) | |||||||||||
Other gain (losses), net |
17 | |||||||||||||||||||
Fair value change of derivative liabilities |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Loss before income tax expenses |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
Income tax expenses |
18 | |||||||||||||||||||
Share of results of equity investees |
( |
) | ( |
) | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Net loss |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
Less: Net income attributable to the non-controlling interest shareholders |
( |
) | ( |
) | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Net loss attributable to Boqii Holding Limited |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
Accretion on convertible redeemable preferred shares to redemption value |
20 | ( |
) | |||||||||||||||||
Accretion on redeemable non-controlling interests to redemption value |
21 | ( |
) | ( |
) | ( |
) | |||||||||||||
Deemed dividend to preferred shareholders |
( |
) | ( |
) | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Net loss attributable to Boqii Holding Limited’s ordinary shareholders |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Net loss |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
Other comprehensive income (loss): |
||||||||||||||||||||
Foreign currency translation adjustment, net of nil tax |
( |
) | ( |
) | ( |
) | ||||||||||||||
Unrealized securities holding gains/(losses) |
( |
) | ( |
) | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total comprehensive loss |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Less: Total comprehensive loss/(income) attributable to non- controlling interests shareholders |
( |
) | ( |
) | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total comprehensive loss attributable to Boqii Holding Limited |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Net loss per share attributable to Boqii Holding Limited’s ordinary shareholders |
||||||||||||||||||||
— basic |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
— diluted |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
Weighted average number of ordinary shares |
||||||||||||||||||||
— basic |
||||||||||||||||||||
— diluted |
Ordinary Shares (US$0.001 per value) |
Additional Paid-in Capital |
Statutory reserves |
Accumulated other comprehensive income |
Accumulated deficit |
Non-controlling interests |
Receivable for issuance of ordinary shares |
Total Shareholders’ Deficit |
|||||||||||||||||||||||||||||
Number of Shares |
Amount |
|||||||||||||||||||||||||||||||||||
RMB | RMB | RMB | RMB | RMB | RMB | RMB | RMB | |||||||||||||||||||||||||||||
Balances as of March 31, 2019 |
— | ( |
) | — | ( |
) | ||||||||||||||||||||||||||||||
Share-based compensation |
( |
) | — | |||||||||||||||||||||||||||||||||
Foreign currency translation adjustment |
— | — | — | — | — | — | — | |||||||||||||||||||||||||||||
Appropriations to statutory reserves |
— | — | — | — | ( |
) | — | — | — | |||||||||||||||||||||||||||
Deemed dividend to preferred shareholders (Note 20) |
— | — | — | — | — | ( |
) | — | — | ( |
) | |||||||||||||||||||||||||
Accretion to redemption value of redeemable convertible preferred shares (Note 20) |
— | — | — | — | — | ( |
) | — | — | ( |
) | |||||||||||||||||||||||||
Unrealized securities holding gains, net of tax |
— | — | — | — | — | — | — | |||||||||||||||||||||||||||||
Acquisition of subsidiaries |
— | — | — | — | ( |
) | — | |||||||||||||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | — | ( |
) | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Balances as of March 31, 2020 |
— | ( |
) | ( |
) | ( |
) | |||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary Shares (US$0.001 per value) |
Class A Ordinary Shares (US$0.001 per value) |
Class B Ordinary Shares (US$0.001 per value) |
Additional Paid-in Capital |
Statutory reserves |
Accumulated other comprehensive income |
Accumulated deficit |
Non-controlling interests |
Receivable for issuance of ordinary shares |
Total Shareholders’ (Deficit)/ Equity |
|||||||||||||||||||||||||||||||||||||||||||
Number of Shares |
Amount |
Number of Shares |
Amount |
Number of Shares |
Amount |
|||||||||||||||||||||||||||||||||||||||||||||||
RMB | RMB | RMB | RMB | RMB | RMB | RMB | RMB | RMB | RMB | |||||||||||||||||||||||||||||||||||||||||||
Balances as of March 31, 2020 |
— | — | — | — | — | ( |
) | ( |
) | ( |
) | |||||||||||||||||||||||||||||||||||||||||
Share-based compensation |
— | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||
Foreign currency translation adjustment |
— | — | — | — | — | — | — | — | ( |
) | — | — | — | ( |
) | |||||||||||||||||||||||||||||||||||||
Appropriations to statutory reserves |
— | — | — | — | — | — | — | — | ( |
) | — | — | — | |||||||||||||||||||||||||||||||||||||||
Deemed dividend to preferred shareholders (Note 20) |
— | — | — | — | — | — | — | — | — | ( |
) | — | — | ( |
) | |||||||||||||||||||||||||||||||||||||
Accretion to redemption value of redeemable convertible preferred shares (Note 20) |
— | — | — | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
Accretion to redemption value of redeemable non-controlling interests (Note 21) |
— | — | — | — | — | — | — | — | — | ( |
) | — | — | ( |
) | |||||||||||||||||||||||||||||||||||||
Unrealized securities holding gains, net of tax |
— | — | — | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
Exercise of CMB Warrant (Note 20) |
— | — | — | — | — | — | — | — | — | ( |
) | — | — | ( |
) | |||||||||||||||||||||||||||||||||||||
Capital contribution from non-controlling interests |
— | — | — | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
Receivable for issuance of convertible redeemable preferred shares |
— | — | — | — | — | — | — | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||||||||||||||||||||
Conversion of ordinary shares into Class A and Class B ordinary shares |
( |
) | ( |
) | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
Issuance of Class A ordinary shares upon initial public offering (“IPO”), net of cost of issuance (Note 19) |
— | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||
Conversion of Series A convertible redeemable preferred shares upon completion of the IPO |
— | — | — | — | — | — | — | — | — |
Ordinary Shares (US$0.001 per value) |
Class A Ordinary Shares (US$0.001 per value) |
Class B Ordinary Shares (US$0.001 per value) |
Additional Paid-in Capital |
Statutory reserves |
Accumulated other comprehensive income |
Accumulated deficit |
Non-controlling interests |
Receivable for issuance of ordinary shares |
Total Shareholders’ (Deficit)/ Equity |
|||||||||||||||||||||||||||||||||||||||||||
Number of Shares |
Amount |
Number of Shares |
Amount |
Number of Shares |
Amount |
|||||||||||||||||||||||||||||||||||||||||||||||
RMB | RMB | RMB | RMB | RMB | RMB | RMB | RMB | RMB | RMB | |||||||||||||||||||||||||||||||||||||||||||
Conversion of Series B convertible redeemable preferred shares upon completion of the IPO |
— | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||
Conversion of Series C convertible redeemable preferred shares upon completion of the IPO |
— | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||
Conversion of Series C+ convertible redeemable preferred shares upon completion of the IPO |
— | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||
Conversion of Series D convertible redeemable preferred shares upon completion of the IPO |
— | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||
Conversion of Series D-1 convertible redeemable preferred shares upon completion of the IPO |
— | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||
Conversion of Series D-2 convertible redeemable preferred shares upon completion of the IPO |
— | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||
Conversion of Series E convertible redeemable preferred shares upon completion of the IPO |
— | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||
Repurchase of Ordinary Shares |
— | — | ( |
) | ( |
) | — | — | ( |
) | — | — | — | — | — | ( |
) | |||||||||||||||||||||||||||||||||||
Net loss |
— | — | — | — | — | — | — | — | — | ( |
) | — | ( |
) | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
Balances as of March 31, 2021 |
— | — | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class A Ordinary Shares (US$0.001 per value) |
Class B Ordinary Shares (US$0.001 per value) |
Additional Paid-in Capital |
Statutory reserves |
Accumulated other comprehensive income |
Accumulated deficit |
Non-controlling interests |
Receivable for issuance of ordinary shares |
Total Shareholders’ Equity |
||||||||||||||||||||||||||||||||||||
Number of Shares |
Amount |
Number of Shares |
Amount |
|||||||||||||||||||||||||||||||||||||||||
RMB | RMB | RMB | RMB | RMB | RMB | RMB | RMB | RMB | ||||||||||||||||||||||||||||||||||||
Balances as of March 31, 2021 |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||
Foreign currency translation adjustment |
— | — | — | — | — | — | ( |
) | — | — | — | ( |
) | |||||||||||||||||||||||||||||||
Accretion on redeemable non-controlling interests to redemption value |
— | — | — | — | — | — | — | ( |
) | — | — | ( |
) | |||||||||||||||||||||||||||||||
Receivable for issuance of ordinary shares (Note 23) |
— | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Unrealized securities holding losses, net of tax |
— | — | — | — | — | — | ( |
) | — | — | — | ( |
) | |||||||||||||||||||||||||||||||
Acquisition of a subsidiary |
— | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Issuance of ordinary shares for the exercise of stock options |
— | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
Capital contribution from non-controlling interests |
— | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Appropriations to statutory reserves |
— | — | — | — | — | — | ( |
) | — | — | — | |||||||||||||||||||||||||||||||||
Share-based compensation |
— | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Net loss |
— | — | — | — | — | — | — | ( |
) | ( |
) | — | ( |
) | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Balances as of March 31, 2022 |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31, |
||||||||||||||||||||
Note |
2020 |
2021 |
2022 |
|||||||||||||||||
RMB |
RMB |
RMB |
US$ (Note 2(f)) |
|||||||||||||||||
Cash flows from operating activities: |
||||||||||||||||||||
Net loss |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
Adjustments to reconcile net loss to net cash provided by operating activities: |
||||||||||||||||||||
Depreciation and amortization expense |
||||||||||||||||||||
Provision for inventories |
( |
) | ||||||||||||||||||
Provision for doubtful accounts |
6 | ( |
) | |||||||||||||||||
Interest expense of other debts |
16 | |||||||||||||||||||
Interest receivable for issuance of ordinary shares |
— | ( |
) | ( |
) | ( |
) | |||||||||||||
Amortization of right-of-use |
15 | |||||||||||||||||||
Interest of lease liabilities |
15 | |||||||||||||||||||
Investment income |
— | — | ||||||||||||||||||
Share of results of equity investees |
( |
) | ( |
) | ||||||||||||||||
Loss /(gain) on disposal of property and equipment |
( |
) | ( |
) | ||||||||||||||||
Gain on disposal of other debts |
( |
) | ( |
) | — | — | ||||||||||||||
Gain from the re-measurement of the previously held equity interest to the fair value in the business acquisition |
17 | ( |
) | — | ( |
) | ( |
) | ||||||||||||
Share-based compensation expense |
2 4 |
— | ||||||||||||||||||
Fair value change of derivative liabilities |
2 6 |
( |
) | ( |
) | ( |
) | ( |
) | |||||||||||
Deferred tax expense |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
Changes in operating assets and liabilities, net of effects of businesses acquired: |
||||||||||||||||||||
Accounts receivable |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
Inventories |
( |
) | ( |
) | ( |
) | ||||||||||||||
Prepayments and other current assets |
( |
) | ( |
) | ( |
) | ||||||||||||||
Amounts due from related parties |
( |
) | ( |
) | ||||||||||||||||
Operating lease liabilities |
15 | ( |
) | ( |
) | ( |
) | ( |
) | |||||||||||
Accounts payable |
( |
) | ( |
) | ||||||||||||||||
Salary and welfare payable |
||||||||||||||||||||
Accrued liabilities and other current liabilities |
||||||||||||||||||||
Amounts due to related parties |
( |
) | ( |
) | ( |
) | ||||||||||||||
Contract liabilities |
( |
) | ||||||||||||||||||
Other non-current assets |
( |
) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Net cash used in operating activities |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Cash flows from investing activities: |
||||||||||||||||||||
Loan receivables advanced to a third party |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
Repayments on loan receivables from a third party |
||||||||||||||||||||
Loan receivables advanced to a related party |
— | ( |
) | ( |
) | ( |
) | |||||||||||||
Repayments on loan receivables from a related party |
— | — | ||||||||||||||||||
Acquisition of subsidiaries, net of cash and cash equivalents acquired |
— | — | — |
|||||||||||||||||
Increase/(decrease) in short-term investments |
— | ( |
) | |||||||||||||||||
Purchase of intangible assets |
( |
) | — | ( |
) | ( |
) | |||||||||||||
Purchase of property and equipment |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
Disposal of property and equipment |
||||||||||||||||||||
Acquisitions of long-term investments |
( |
) | — | ( |
) | ( |
) | |||||||||||||
Disposal of equity investees |
— | — | — | |||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Net cash generated from/ ( used in ) investing activities |
( |
) | ( |
) | ||||||||||||||||
|
|
|
|
|
|
|
|
Year Ended March 31, |
||||||||||||||||||||
Note |
2020 |
2021 |
2022 |
|||||||||||||||||
RMB |
RMB |
RMB |
US$ (Note 2(f)) |
|||||||||||||||||
Cash flows from financing activities: |
||||||||||||||||||||
Proceeds from issuance of convertible redeemable preferred shares , net of issuance costs |
— | — | ||||||||||||||||||
Acquisition of additional interests in subsidiaries from non-controlling interests |
— |
— |
||||||||||||||||||
Proceeds from short-term and long-term borrowings |
||||||||||||||||||||
Repayments of short-term and long-term borrowings |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
Proceeds from issuance of other debts, net of issuance costs |
— | — | ||||||||||||||||||
Proceeds from issuance of ordinary shares |
— | — | ||||||||||||||||||
Repayments of other debts |
— | ( |
) | ( |
) | ( |
) | |||||||||||||
Proceeds from exercise of share option |
— | |||||||||||||||||||
Proceeds from the initial public offering, net of underwriter discounts and commissions and other offering costs paid |
— | — | — | |||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Net cash flows generated from financing activities |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Net increase (decrease) in cash, cash equivalents and restricted cash |
( |
) | ( |
) | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Cash, cash equivalents and restricted cash at beginning of year |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Effects of exchange rate changes on cash, cash equivalents and restricted cash |
( |
) | ( |
) | ( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Cash, cash equivalents and restricted cash at end of year |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Supplemental schedule of non-cash investing and financing activities: |
||||||||||||||||||||
Accretion on convertible redeemable preferred shares |
( |
) | — | — | ||||||||||||||||
Accretion on redeemable non-controlling interests |
— | ( |
) | ( |
) | ( |
) | |||||||||||||
Deemed dividend to preferred shareholders |
( |
) | ( |
) | — | — | ||||||||||||||
Non-cash consideration paid for business acquisitions |
( |
) | — | — | — | |||||||||||||||
Unpaid cash consideration for business acquisitions |
— | — | ( |
) | ( |
) | ||||||||||||||
Additional ASC 842 supplemental disclosure: |
||||||||||||||||||||
Cash paid for fixed operating lease costs included in the measurement of lease obligations in operating activities |
||||||||||||||||||||
Right-of-use |
1. |
Organization and principal activities |
Name of subsidiaries and VIE |
Place of incorporation |
Date of incorporation or acquisition |
Percentage of direct or indirect |
Principal activities | ||||||
Subsidiaries: |
||||||||||
Boqii Corporation Limited (“Boqii Corporation”) |
July 2012 | % | ||||||||
Boqii International Limited |
August 2016 | % | ||||||||
Xingmu International Limited |
August 2019 | % | ||||||||
Xingmu HK Limited |
November 2019 | % | ||||||||
Nanjing Xinmu Information Technology Co., Ltd. (“Xingmu WFOE”) |
November 2019 | % | Technology development and sales of merchandise | |||||||
Xincheng (Shanghai) Information Technology Co., Ltd. (“Shanghai Xincheng”) |
November 2012 | % | Technology development and sales of merchandise | |||||||
Shanghai Yiqin Pets Products Co., Ltd. |
February 2013 | % | Technology development and sales of merchandise | |||||||
Consolidated VIEs |
||||||||||
Guangcheng (Shanghai) Information Technology Co., Ltd. |
November 2012 | % | ||||||||
Nanjing Xingmu Biotechnology Co., Ltd. (“Nanjing Xingmu”) |
November 2019 | % | ||||||||
Suzhou Taicheng Supply Chain Co., Ltd. (“Suzhou Taicheng”) |
June 2021 | % | ||||||||
Subsidiaries of VIEs |
||||||||||
Boqii (Shanghai) Information Technology Co., Ltd. |
August 2014 | % | ||||||||
Tianjing Guangcheng Information Technology Co., Ltd. |
June 2017 | % | ||||||||
Nanjing Cuida Biotechnology Co. Ltd.(“Cuida”) |
April 2017 | % | ||||||||
Taizhou Xingmu Biotechnology Co., Ltd. |
November 2019 | % |
1. |
Organization and principal activities (continued) |
1. |
Organization and principal activities (continued) |
1. |
Organization and principal activities (continued) |
1. |
Organization and principal activities (continued) |
As of March 31, |
||||||||
2021 |
2022 |
|||||||
RMB |
RMB |
|||||||
Cash and cash equivalents |
||||||||
Accounts receivable, net |
||||||||
Amounts due from related parties |
||||||||
Inventories, net |
||||||||
Prepayments and other current assets |
||||||||
Intra-Group receivables due from the Group’s entities |
||||||||
Property and equipment, net |
||||||||
Intangible assets |
||||||||
Operating lease right-of-use |
||||||||
Goodwill |
||||||||
Long-term investments |
||||||||
Other non-current asset |
||||||||
|
|
|
|
|||||
Total assets |
|
|
||||||
|
|
|
|
As of March 31, |
||||||||
2021 |
2022 |
|||||||
RMB |
RMB |
|||||||
Short-term borrowings |
||||||||
Accounts payable |
||||||||
Amounts due to related parties, current |
||||||||
Salary and welfare payable |
||||||||
Accrued liabilities and other current liabilities |
||||||||
Contract liabilities |
||||||||
Operating lease liabilities, current |
||||||||
Intra-Group payables due to the Group’s entities |
||||||||
Deferred tax liabilities |
( |
) | ||||||
Operating lease liabilities, non-current |
||||||||
Long-term borrowings |
— | |||||||
Other debts, non-current |
||||||||
|
|
|
|
|||||
Total liabilities |
||||||||
|
|
|
|
1. |
Organization and principal activities (continued) |
Year Ended March 31, |
||||||||||||
2020 |
2021 |
2022 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Net revenues: |
||||||||||||
Third-party revenues |
||||||||||||
Intra-Group revenues |
||||||||||||
|
|
|
|
|
|
|||||||
Total revenues |
||||||||||||
Cost of revenues: |
||||||||||||
Third-party cost of revenues |
( |
) | ( |
) | ( |
) | ||||||
Intra-Group cost of revenues |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Total cost of revenues |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Gross profit |
||||||||||||
Operating expenses: |
||||||||||||
Third-party operating expenses |
( |
) | ( |
) | ( |
) | ||||||
Intra-Group operating expenses |
— | ( |
) | — | ||||||||
|
|
|
|
|
|
|||||||
Total operating expenses |
( |
) | ( |
) | ( |
) | ||||||
Other income, net |
||||||||||||
|
|
|
|
|
|
|||||||
Loss from operations |
( |
) | ( |
) | ( |
) | ||||||
Non-operating income /(expense) |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Loss before income tax expenses |
( |
) | ( |
) | ( |
) | ||||||
Income tax benefits/(expenses) |
( |
) | ||||||||||
Share of results of equity investees |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Net loss |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Cash flows from operating activities: |
||||||||||||
Net cash provided by transactions with external parties |
||||||||||||
Net cash used in transactions with the Group’s entities |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Net cash generated from operating activities |
||||||||||||
|
|
|
|
|
|
|||||||
Cash flows from investing activities: |
||||||||||||
Other investing activities |
( |
) | ( |
) | ( |
) | ||||||
Cash flows of loan funding provided to the Group’s entities, net of repayments received |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Net cash used in investing activities |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Cash flows from financing activities: |
||||||||||||
Other financing activities |
( |
) | ( |
) | ||||||||
Cash flows of loan funding received from the Group’s entities, net of repayments made |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Net cash generated from/ (used in) financing activities |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
2. |
Principal Accounting Policies |
2. |
Principal Accounting Policies (continued) |
2. |
Principal Accounting Policies (continued) |
2. |
Principal Accounting Policies (continued) |
Useful years | ||
Warehouse equipment |
||
Furniture, computer and office equipment |
||
Vehicles |
||
Software |
||
Leasehold improvements |
2. |
Principal Accounting Policies (continued) |
Useful years | ||
Trademark |
||
Dealership |
||
License |
2. |
Principal Accounting Policies (continued) |
2. |
Principal Accounting Policies (continued) |
2. |
Principal Accounting Policies (continued) |
2. |
Principal Accounting Policies (continued) |
2. |
Principal Accounting Policies (continued) |
2. |
Principal Accounting Policies (continued) |
2. |
Principal Accounting Policies (continued) |
3. |
Business combinations |
3. |
Business combinations (continued) |
As of June 30, 2021 |
||||
RMB |
||||
Total purchase price is comprised of: |
||||
- fair value of |
||||
- cash consideration |
||||
|
|
|||
Fair value of total consideration |
||||
|
|
|||
Cash and cash equivalents |
||||
Prepayments and other current assets |
||||
|
|
|||
Total assets |
||||
|
|
|||
Accrued liabilities and other current liabilities |
( |
) | ||
|
|
|||
Total liabilities |
( |
) | ||
|
|
|||
Net assets acquired |
||||
|
|
|||
Goodwill |
||||
Non-controlling interests |
( |
) | ||
|
|
|||
Total |
||||
|
|
4. |
Risks and Concentration |
4. |
Risks and Concentration (continued) |
Year Ended March 31, 2020 |
Year Ended March 31, 2021 |
Year Ended March 31, 2022 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Royal Canin China Co., Ltd. |
% | % | % |
5. |
Cash and cash equivalents |
As of March 31, 2021 |
As of March 31, 2022 |
|||||||||||||||
RMB |
RMB |
|||||||||||||||
Amount |
equivalent |
Amount |
equivalent |
|||||||||||||
RMB |
||||||||||||||||
Hong Kong dollars |
||||||||||||||||
US$ |
||||||||||||||||
EUR |
||||||||||||||||
NZD |
||||||||||||||||
|
|
|
|
|||||||||||||
Total |
||||||||||||||||
|
|
|
|
6. |
Accounts receivable, net |
As of March 31, |
As of March 31, |
|||||||
2021 |
2022 |
|||||||
RMB |
RMB |
|||||||
Accounts receivable - Product sales |
||||||||
Accounts receivable - Online marketing and information service and other service |
||||||||
Allowance of doubtful accounts |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total |
||||||||
|
|
|
|
As of March 31, |
As of March 31, |
As of March 31, |
||||||||||
2020 |
2021 |
2022 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
At beginning of year |
||||||||||||
Addition/(reversal) |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
At end of year |
||||||||||||
|
|
|
|
|
|
7. |
Inventories, net of inventory reserves |
As of March 31, |
As of March 31, |
|||||||
2021 |
2022 |
|||||||
RMB |
RMB |
|||||||
Products |
||||||||
Packaging materials and others |
||||||||
|
|
|
|
|||||
Total inventories, net of inventory reserves |
||||||||
|
|
|
|
As of March 31, |
As of March 31, |
As of March 31, |
||||||||||
2020 |
2021 |
2022 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
At beginning of year |
||||||||||||
Provision/(reversal) |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
At end of year |
||||||||||||
|
|
|
|
|
|
8. |
Prepayments and other current assets |
As of March 31, 2021 |
As of March 31, 2022 |
|||||||
RMB |
RMB |
|||||||
Prepayments for purchases of products (a) |
||||||||
Vendor rebate receivables (b) |
||||||||
Value-added tax (“VAT”) deductible (c) |
||||||||
Loan receivables (d) |
||||||||
Sales return assets |
||||||||
Deposits |
||||||||
Others |
||||||||
|
|
|
|
|||||
Total |
||||||||
|
|
|
|
(a) |
Prepayments for purchases of products represent cash prepaid to the Company’s third-party brand partners for the procurement of products. |
(b) |
Vendor rebate receivables represent the rebates to be received by the Company from its suppliers after certain levels of purchases are achieved. |
(c) |
VAT recoverable represents the balances that the Company can utilize to deduct its value-added tax liabilities within the next 12 months. |
(d) |
The balance represents loan receivables due from certain third-party companies and individuals. From April 2020 to October 2021, the Company entered into several loan agreements with aggregate principal amount of RMB |
9. |
Property and equipment, net |
As of March 31, 2021 |
As of March 31, 2022 |
|||||||
RMB |
RMB |
|||||||
Cost: |
||||||||
Warehouse equipment |
||||||||
Furniture, computer and office equipment |
||||||||
Vehicles |
||||||||
Leasehold improvement |
||||||||
Software |
||||||||
|
|
|
|
|||||
Total cost |
||||||||
Less: Accumulated depreciation |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Property and equipment, net |
||||||||
|
|
|
|
10. |
Intangible assets, net |
As of March 31, 2021 |
As of March 31, 2022 |
|||||||
RMB |
RMB |
|||||||
Cost: |
||||||||
Trademark |
||||||||
License |
||||||||
Dealership |
||||||||
|
|
|
|
|||||
Total cost |
||||||||
Less: Accumulated amortization |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Intangible assets, net |
||||||||
|
|
|
|
As of March 31, |
||||||||||||||||||||
2023 |
2024 |
2025 |
2026 |
2027 |
||||||||||||||||
Amortization expenses |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
11. |
Long-term investments |
As of March 31, 2021 |
As of March 31, 2022 |
|||||||
RMB |
RMB |
|||||||
Equity method investments |
||||||||
Available-for-sale |
||||||||
Equity securities with readily determinable fair values |
||||||||
|
|
|
|
|||||
Total |
||||||||
|
|
|
|
Cost | Gross unrealized gains | Gross unrealized losses | Fair value | |||||||||||||
Unlisted debt securities |
||||||||||||||||
|
|
|
|
|
|
|
|
Cost | Gross unrealized gains | Gross unrealized losses | Fair value | |||||||||||||
Unlisted debt securities |
( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
11. |
Long-term investments (continued) |
Cost | Gross unrealized gains | Gross unrealized losses | Fair value | |||||||||||||
L isted company |
( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
12. |
Goodwill |
Total | ||||
RMB | ||||
Balance as of March 31, 2020 |
||||
Goodwill |
||||
Accumulated impairment loss |
||||
|
|
|||
|
|
|||
Balance as of March 31, 2021 |
||||
Goodwill |
||||
Accumulated impairment loss |
||||
|
|
|||
|
|
|||
Transaction during the year |
||||
Additions (Note 3) |
||||
|
|
|||
Balance as of March 31, 2022 |
||||
Goodwill |
||||
Accumulated impairment loss |
||||
|
|
|||
|
|
13. |
Other non-current Assets |
As of March 31, 2021 |
As of March 31, 2022 |
|||||||
RMB |
RMB |
|||||||
Deposits (a) |
||||||||
Long-term loan receivables (b) |
||||||||
|
|
|
|
|||||
|
|
|
|
(a) |
Deposits mainly consisted of rental deposits and deposit for online stores operated on third party platforms, which will be collected after one year. |
(b) |
From December 2019 to December 2021, the Company entered into interest free loan agreements with three third parties for total principal amounts of RMB |
14. |
Accrued liabilities and other current liabilities |
As of March 31, 2021 |
As of March 31, 2022 |
|||||||
RMB |
RMB |
|||||||
Logistics expenses payables |
||||||||
Advances from customers |
||||||||
Payable for investment (Note (11)) |
||||||||
Refund obligation of sales returns |
||||||||
Professional service fee accruals |
||||||||
Accrued advertising expenses |
||||||||
Others |
||||||||
|
|
|
|
|||||
Total |
||||||||
|
|
|
|
15. |
Leases |
15. |
Leases (continued) |
As of March 31, 2021 |
As of March 31, 2022 |
|||||||
RMB |
RMB |
|||||||
Assets |
||||||||
Operating lease right-of-use |
||||||||
|
|
|
|
|||||
Liabilities |
||||||||
Operating lease liabilities, current |
||||||||
Operating lease liabilities, non-current |
||||||||
|
|
|
|
|||||
Total operating lease liabilitie s |
|
|
|
|
|
|
|
|
Weighted average remaining lease term (years) |
||||||||
Weighted average discount rate |
% | % |
Year ended March 31, 2020 |
Year ended March 31, 2021 |
Year ended March 31, 2022 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Operating lease right-of-use |
||||||||||||
|
|
|
|
|
|
|||||||
Operating lease related expenses |
||||||||||||
Amortization of right-of-use |
||||||||||||
Interest of lease liabilities |
||||||||||||
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
Year ended March 31, 2020 |
Year ended March 31, 2021 |
Year ended March 31, 2022 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Operating lease payments (included in measurement of lease liabilities) |
||||||||||||
|
|
|
|
|
|
Year ended March 31, 2022 |
||||
RMB |
||||
For the year ending March 31, |
||||
2023 |
||||
2024 |
||||
2025 |
||||
2026 |
||||
2027 |
||||
|
|
|||
Total lease payments |
||||
Less: imputed interest |
( |
) | ||
|
|
|||
Total |
||||
|
|
16. |
Interest expense |
Year ended March 31, 2020 |
Year ended March 31, 2021 |
Year ended March 31, 2022 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Amortization charges on promissory notes |
||||||||||||
Interest expense on borrowings |
||||||||||||
Others |
||||||||||||
|
|
|
|
|
|
|||||||
Total |
||||||||||||
|
|
|
|
|
|
17. |
Other gains (losses), net |
Year ended March 31, 2020 |
Year ended March 31, 2021 |
Year ended March 31, 2022 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Gain from the re-measurement of the previously held equity interests to the fair value in the step acquisitions (Note 3) |
||||||||||||
Foreign exchange losses, net |
( |
) | ( |
) | ||||||||
Gain on disposal of other debts (Note 22) |
||||||||||||
Reimbursement from a depositary bank (a) |
||||||||||||
Investment loss (Note 11) |
( |
) | ||||||||||
Others |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
(a) |
The Company received a reimbursement of US$ |
18. |
Income taxes |
18. |
Income taxes (continued) |
Year ended March 31, 2020 |
Year ended March 31, 2021 |
Year ended March 31, 2022 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Loss before income taxes |
( |
) | ( |
) | ( |
) | ||||||
Income tax computed at respective applicable tax rate s |
( |
) | ( |
) | ( |
) | ||||||
Effect of different tax jurisdiction |
||||||||||||
Super deduction for research and development expenses (a) |
( |
) | ( |
) | ( |
) | ||||||
Non-deductible expenses |
||||||||||||
Change in valuation allowance |
||||||||||||
|
|
|
|
|
|
|||||||
Total |
||||||||||||
|
|
|
|
|
|
(a) | According to the relevant laws and regulations promulgated by the State Administration of Tax of the PRC, from 2018 onwards, enterprises engaging in research and development activities are entitled to claim of qualified research and development expenses (the “Super Deduction”) can be directly claimed in the annual EIT filing. For the years end March 31, 2020, 2021 and 2022, the Super Deduction for research and development expenses available to the Company amounted to RMB |
18. |
Income taxes (continued) |
Year ended March 31, 2020 |
Year ended March 31, 2021 |
Year ended March 31, 2022 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Tax holiday effect |
( |
) | ||||||||||
Basic and diluted net loss per share effect |
( |
) | ||||||||||
|
|
|
|
|
|
Year ended March 31, 2020 |
Year ended March 31, 2021 |
Year ended March 31, 2022 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
PRC statutory income tax rates |
% | % | % | |||||||||
Tax holiday effec t |
|
|
( |
%) |
|
|
|
% |
|
|
|
% |
Difference in tax rates of subsidiaries outside PRC |
( |
%) | ( |
%) | ( |
%) | ||||||
Super deduction for research and development expenses |
% | % | % | |||||||||
Non-deductible expenses |
% | % | % | |||||||||
Change in valuation allowance |
( |
%) | ( |
%) | ( |
%) | ||||||
|
|
|
|
|
|
|||||||
Effective income tax rate |
% | % | % | |||||||||
|
|
|
|
|
|
Year ended March 31, 2020 |
Year ended March 31, 2021 |
Year ended March 31, 2022 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Current income tax expense/(benefit) |
( |
) | ||||||||||
Deferred tax expense/(benefit) |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Income tax credit, net |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
18. |
Income taxes (continued) |
As of March 31, 2021 |
As of March 31, 2022 |
|||||||
RMB |
RMB |
|||||||
Deferred tax assets: |
||||||||
Net accumulated loss-carry forward |
||||||||
Deferred deductible advertising expense |
||||||||
Allowance |
||||||||
Contract liabilities |
||||||||
Accruals |
||||||||
Less: Valuation allowance |
( |
) | ( |
) | ||||
|
|
|
|
|||||
|
||||||||
|
|
|
|
|||||
Deferred tax liabilities: |
||||||||
Recognition of intangible assets arising from asset acquisition and business combination |
( |
) |
( |
) | ||||
Unrealized fair value change of the available-for-sale |
( |
) |
||||||
|
|
|
|
|||||
Net deferred tax liabilities |
( |
) |
( |
) | ||||
|
|
|
|
As of March 31, 2021 |
As of March 31, 2022 |
|||||||
RMB |
RMB |
|||||||
Beginning balance |
||||||||
Change of valuation allowance |
||||||||
|
|
|
|
|||||
Ending balance |
||||||||
|
|
|
|
19. |
Ordinary Share |
20. |
Convertible redeemable preferred shares |
20. |
Convertible redeemable preferred shares (continued) |
• | The investor shall exercise the CMB Warrant at an exercise price of US$6.86 per share for 6,734,459 Series C+ Preferred Shares. |
• | Guangcheng shall repay the CMB Investment to the investor two years after this agreement is signed. |
• | The investor shall pay the exercise price of the CMB Warrant to the Company immediately after receiving the repayment of the CMB Investment from Guangcheng. |
20. |
Convertible redeemable preferred shares (continued) |
20. |
Convertible redeemable preferred shares (continued) |
20. |
Convertible redeemable preferred shares (continued) |
(1) | Holders of the Series E Preferred Shares shall be entitled to receive a per share amount equal to |
(2) | Holders of Series D-3 Preferred Shares shall be entitled to receive a per share amount equal to D-3 Preferred Shares, plus all declared but unpaid dividends. |
(3) | Holders of Series D-2 Preferred Shares shall be entitled to receive a per share amount equal to D-2 Preferred Shares, plus all declared but unpaid dividends. |
(4) | Holders of the Series D-1 Preferred Shares shall be entitled to receive a per share amount equal to D-1 Preferred Shares, plus all declared but unpaid dividends. |
(5) | Holders of the Series D Preferred Shares shall be entitled to receive a per share amount equal to |
(6) | Holders of the Series C+ Preferred Shares shall be entitled to receive a per share amount equal to |
(7) | Holders of the Series C Preferred Shares shall be entitled to receive a per share amount equal to |
(8) | Holders of the Series B Preferred Shares shall be entitled to receive a per share amount equal to |
(9) | Holders of the Series A Preferred Shares shall be entitled to receive a per share amount equal to |
20. |
Convertible redeemable preferred shares (continued) |
• | Series A and B Preferred Shares – the higher of (1) the sum of |
• | All other series of the Preferred Shares – the higher of (1) the sum of issue price, interest calculated at |
20. |
Convertible redeemable preferred shares (continued) |
Series A Preferred Shares |
Series B Preferred Shares |
Series C Preferred Shares |
Series C+ Preferred Shares |
Series D Preferred Shares |
Series D-1 PreferredShares |
Series D-2 PreferredShares |
Series E Preferred Shares |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of shares |
Amount (RMB) |
Number of shares |
Amount (RMB) |
Number of shares |
Amount (RMB) |
Number of shares |
Amount (RMB) |
Number of shares |
Amount (RMB) |
Number of shares |
Amount (RMB) |
Number of shares |
Amount (RMB) |
Number of shares |
Amount (RMB) |
|||||||||||||||||||||||||||||||||||||||||||||||||
Balance as of March 31, 2019 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance (Note a) |
— | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accretion on the Preferred Shares to redemption value |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deemed dividend to preferred shareholders (Note b) |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balances as of March 31, 2020 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance (Note a) |
— | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accretion on the Preferred Shares to redemption value |
— | ( |
) | — | ( |
) | — | ( |
) | — | — | ( |
) | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||
Deemed dividend to preferred shareholders (Note b) |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
Conversion of convertible redeemable preferred shares upon completion of the IPO |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
Balances as of March 31, 2021 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21. |
Redeemable non-controlling interests |
22. |
Borrowings, other debts and derivative liabilities |
As of March 31, |
As of March 31, |
|||||||
2021 |
2022 |
|||||||
RMB |
RMB |
|||||||
Bank borrowings |
||||||||
Current portion of long-term bank borrowings |
— | |||||||
|
|
|
|
|||||
Total |
||||||||
|
|
|
|
As of March 31, |
As of March 31, |
|||||||
2021 |
2022 |
|||||||
RMB |
RMB |
|||||||
Bank borrowings |
||||||||
|
|
|
|
|||||
Total |
||||||||
|
|
|
|
22. |
Borrowings, other debts and derivative liabilities (continued) |
Year ended March 31, 2021 |
Year ended March 31, 2022 |
|||||||
RMB |
RMB |
|||||||
For the year ending March 31, |
||||||||
- Within 1 year |
||||||||
- Between 1 and 2 years |
||||||||
|
|
|
|
|||||
Total |
||||||||
|
|
|
|
As of March 31, |
As of March 31, |
|||||||
2021 |
2022 |
|||||||
RMB |
RMB |
|||||||
Loan for Series C+ Warrant (Note 20) |
||||||||
Loan from Chong Li (a) (b) |
||||||||
Loan for Yoken Series A-1 Warrant (g) |
||||||||
Payable for investment (Note 11) |
— | |||||||
|
|
|
|
|||||
Total |
||||||||
|
|
|
|
22. |
Borrowings, other debts and derivative liabilities (continued) |
• | Series D-1 Warrant, Loan for Series D-1 Warrant, Series D-2 Warrant and Loan for Series D-2 Warrant were terminated entirely. |
• | The investor of Loan for Series D-1 Warrant and Loan for Series D-2 Warrant transferred all its creditor’s rights to Chong Li, who separately signed a loan agreement with Guangcheng for the transferred creditor’s rights (“Loan from Chong Li”). Loan from Chong Li is interest-free with a principal amount of RMBD-1 Warrant of RMB66.5 million and Loan for Series D-1 Warrant of RMB61.96 million). The term is |
• | The Company entered into share purchase agreements with Superb Origin, pursuant to which D-1 Preferred Shares and D-2 Preferred Shares were issued to Superb Origin for an aggregate consideration of US$ |
22. |
Borrowings, other debts and derivative liabilities (continued) |
22. |
Borrowings, other debts and derivative liabilities (continued) |
22. |
Borrowings, other debts and derivative liabilities (continued) |
As of March 31, |
As of March 31, |
|||||||
2021 |
2022 |
|||||||
RMB |
RMB |
|||||||
Conversion feature of Yoken Series A-1 Warrant (a) |
||||||||
Series E Warrant (b) |
— |
|||||||
Forward exchange contracts (c) |
— |
|||||||
|
|
|
|
|||||
Total |
||||||||
|
|
|
|
22. |
Borrowings, other debts and derivative liabilities (continued) |
23. |
Receivable for issuance of ordinary shares |
24. |
Share-based compensation |
24. |
Share-based compensation (continued) |
Number of shares |
Weighted average exercise price |
Weighted average remaining contractual term |
Aggregate intrinsic value |
Weighted average fair value |
||||||||||||||||
US$ |
US$ |
US$ |
||||||||||||||||||
Outstanding as of March 31, 2020 |
||||||||||||||||||||
Exercisable as of March 31, 2020 |
— | — | ||||||||||||||||||
Granted |
||||||||||||||||||||
Forfeited |
( |
) | ||||||||||||||||||
Outstanding as of March 31, 2021 |
||||||||||||||||||||
Exercisable as of March 31, 2021 |
— | — | ||||||||||||||||||
Granted |
||||||||||||||||||||
Exercised |
( |
) | ||||||||||||||||||
Forfeited |
( |
) | ||||||||||||||||||
Outstanding as of March 31, 2022 |
||||||||||||||||||||
Exercisable as of March 31, 2022 |
— | — |
Year ended March 31, 2021 |
Year ended March 31, 2022 | |||
Expected volatility |
||||
Risk-free interest rate |
||||
Exercise multiple |
||||
Expected dividend yield |
||||
Contractual term (in years) |
2 4 . |
Share-based compensation (continued) |
2 5 . |
Employee benefits |
2 6 . |
Fair value measurements |
Fair value measurement at reporting date using | ||||||||||||||||
Description |
Fair value as of March 31, 2021 |
Quoted price in active markets for identical assets (Level 1) |
Significant other observable Inputs (Level 2) |
Significant unobservable Inputs (Level 3) |
||||||||||||
RMB | RMB | RMB | RMB | |||||||||||||
Assets: |
||||||||||||||||
Short-term investments |
— | — | ||||||||||||||
Available-for-sale |
— | — | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total assets |
— | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Liabilities: |
||||||||||||||||
Derivative liabilities |
— | |||||||||||||||
|
|
|
|
|
|
|
|
2 6 . |
Fair value measurements (continued) |
Fair value measurement at reporting date using | ||||||||||||||||
Description |
Fair value as of March 31, 2022 |
Quoted price in active markets for identical assets (Level 1) |
Significant other observable Inputs (Level 2) |
Significant unobservable Inputs (Level 3) |
||||||||||||
RMB | RMB | RMB | RMB | |||||||||||||
Assets: |
||||||||||||||||
Short-term investments |
— | — | ||||||||||||||
Available-for-sale |
— | — | ||||||||||||||
Equity securities with readily determinable fair values |
— | — | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total assets |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Liabilities: |
||||||||||||||||
Derivative liabilities |
— | |||||||||||||||
|
|
|
|
|
|
|
|
Derivative liabilities | Available-for-sale debt investments |
|||||||
Fair value of Level 3 investments as at March 31, 2019 |
||||||||
New addition |
||||||||
Conversion of Series D-1 Notes (Note 20) |
( |
) | — | |||||
Conversion of Series D-2 Notes (Note 20) |
( |
) | — | |||||
Unrealized fair value change of the derivative liabilities |
( |
) | — | |||||
Unrealized fair value change of the available-for-sale |
— | |||||||
|
|
|
|
|||||
Fair value of Level 3 investments as at March 31, 2020 |
||||||||
|
|
|
|
|||||
New addition |
||||||||
Disposal of Series D-3 Notes (Note 20) |
( |
) | — | |||||
Unrealized fair value change of the derivative liabilities |
( |
) | — | |||||
Unrealized fair value change of the available-for-sale |
— | |||||||
|
|
|
|
|||||
Fair value of Level 3 investments as at March 31, 2021 |
||||||||
|
|
|
|
|||||
New addition |
||||||||
Reclassification of forward exchange contracts |
— | |||||||
Unrealized fair value change of the derivative liabilities |
( |
) | — | |||||
Unrealized fair value change of the available-for-sale |
— | ( |
) | |||||
|
|
|
|
|||||
Fair value of Level 3 investments as at March 31, 2022 |
||||||||
|
|
|
|
As of March 31, 2021 |
As of March 31, 2022 | |||
Weighted average cost of capital |
||||
Lack of marketability discount |
||||
Risk-free rate |
, ,, ,, , | |||
Expected volatility |
||||
Probability |
Liquidation scenario: Redemption scenario: IPO scenario: |
Liquidation scenario: Redemption scenario: IPO scenario: |
2 6 . |
Fair value measurements (continued) |
As of March 31, 2021 |
As of March 31, 2022 | |||
Spot price (US$) |
||||
Risk-free rate |
||||
Expected volatility |
||||
Expected expiry years (in years) |
2 7 . |
Net loss per share |
Year Ended March 31, 2020 |
Year Ended March 31, 2021 |
Year Ended March 31, 2022 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Numerator: |
||||||||||||
Net loss attributable to Boqii Holding Limited |
( |
) | ( |
) | ( |
) | ||||||
Accretion on the Preferred Shares to redemption value (Note 20) |
( |
) | ||||||||||
Accretion on the Redeemable non-controlling interests to redemption value (Note 21) |
( |
) | ( |
) | ||||||||
Deemed dividend to preferred shareholders |
( |
) | ( |
) | ||||||||
Net loss attributable to ordinary shareholders |
( |
) | ( |
) | ( |
) | ||||||
Denominator: |
||||||||||||
Weighted average number of ordinary shares used in computing net loss per share, Basic and diluted (Note (a)) |
||||||||||||
Net loss per share attributable to ordinary shareholders: |
||||||||||||
Basic and diluted |
( |
) | ( |
) | ( |
) | ||||||
2 7 . |
Net loss per share (continued) |
Year Ended March 31, 2020 |
Year Ended March 31, 2021 |
Year Ended March 31, 2022 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Preferred Shares - weighted average |
||||||||||||
Share options - weighted average |
2 8 . |
Related party transactions |
Name of related parties |
Relationship with the Company | |
Year Ended March 31, 2020 |
Year Ended March 31, 2021 |
Year Ended March 31, 2022 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Sales of goods |
||||||||||||
Beijing Petdog |
||||||||||||
28. |
Related party transactions (continued) |
Year Ended March 31, 2020 |
Year Ended March 31, 2021 |
Year Ended March 31, 2022 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Online marketing and information services |
||||||||||||
Beijing Petdog |
||||||||||||
Weishi Network |
||||||||||||
Year Ended March 31, 2020 |
Year Ended March 31, 2021 |
Year Ended March 31, 2022 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Purchase of merchandise |
||||||||||||
Nanjing Xingmu |
||||||||||||
Weishi Network |
||||||||||||
Nanjing Animal Pharmaceutical |
||||||||||||
Year Ended March 31, 2020 |
Year Ended March 31, 2021 |
Year Ended March 31, 2022 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Loans granted to related parties |
||||||||||||
Shanghai Guangcheng Information (a) |
||||||||||||
Wuhan Chunzhijin (b) |
||||||||||||
Yingzhi (Lisa) Tang |
||||||||||||
Lijun Zhou |
||||||||||||
Yan Jiang |
||||||||||||
Nanjing Animal Pharmaceutical (c) |
||||||||||||
Ying (Christina) Zhang |
||||||||||||
Di (Jackie) Chen |
||||||||||||
Fei Wang |
||||||||||||
(a) | In April 2021, the Company granted Shanghai Guangcheng Information a short-term loan with a total principal amount of RMBmillion (equivalent to USD The loan was fully repaid by March 31, 2022. |
(b) | From April 2020 to January 2021, the Company provided interest free loans to Wuhan Chunzhijin with an aggregate amount of RMBmillion, which will be repaid on demand. |
(c) | In December 2019, Nanjing Xingmu, one of the Company’ subsidiaries, entered into a twelve-month interest free loan agreement with Nanjing Agricultural Pharmaceutical for a principal amount of RMBThe loan was repaid in June 2021. |
28. |
Related party transactions (continued) |
Year Ended March 31, 2020 |
Year Ended March 31, 2021 |
Year Ended March 31, 2022 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Staff advances |
||||||||||||
Yingzhi (Lisa) Tang |
||||||||||||
Di (Jackie) Chen |
||||||||||||
Advances provided to related parties |
||||||||||||
Nanjing Animal Pharmaceutical |
||||||||||||
Wuhan Chunzhijin |
||||||||||||
Loans granted from related parties |
||||||||||||
Shanghai Guangcheng Information (a) |
||||||||||||
Yingzhi (Lisa) Tang (b) |
||||||||||||
Di (Jackie) Chen (c) |
||||||||||||
Yan Jiang (d) |
||||||||||||
(a) | In April 2021, the Company obtained a total loan facility up to USD million from Shanghai Guangcheng Information. During the year ended March 31, 2022, the Company drew down a total amount of USDfrom the loan facility, with interest bearing at |
(b) | In September 2019, the Company obtained a two-year loan of RMB |
(c) | In October 2019, Di (Jackie) Chen advanced RMB |
(d) | In September 2019, the Company obtained a two-year loan of RMB |
2 8 . |
Related party transactions (continued) |
As of March 31, 2020 |
As of March 31, 2021 |
As of March 31, 2022 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Trade receivables from related parties |
||||||||||||
Beijing Petdog |
||||||||||||
|
|
|
|
|
|
|||||||
Prepayments to related parties |
||||||||||||
Nanjing Animal Pharmaceutical |
||||||||||||
Weishi Network |
||||||||||||
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
As of March 31, 2020 |
As of March 31, 2021 |
As of March 31, 2022 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Other receivables from related parties |
||||||||||||
Wuhan Chunzhijin |
||||||||||||
|
|
|
|
|
|
|||||||
Loans to related parties |
||||||||||||
Nanjing Animal Pharmaceutical |
||||||||||||
Yingzhi (Lisa) Tang |
||||||||||||
Yan Jiang |
||||||||||||
Di (Jackie) Chen (a) |
||||||||||||
Ying (Christina) Zhang |
||||||||||||
Fei Wang (b) |
||||||||||||
Lijun Zhou |
||||||||||||
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
(a) | In December 2019, the Company entered into a twelve-month interest free loan agreement with, Di (Jackie) Chen, for a principal amount of RMB million. In December 2020, the loan contract was renewed to June 2023 and was recorded as other non-current assets as of March 31, 2022. |
(b) | In January 2021, the Company entered into a one-year loan agreement with Fei Wang, for a principal amount of RMB l oan was pledged by |
28. |
Related party transactions (continued) |
As of March 31, 2020 |
As of March 31, 2021 |
As of March 31, 2022 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Trade payables to related parties |
||||||||||||
Nanjing Animal Pharmaceutical |
||||||||||||
|
|
|
|
|
|
As of March 31, 2020 |
As of March 31, 2021 |
As of March 31, 2022 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Advances from related parties |
||||||||||||
Beijing Petdog |
||||||||||||
|
|
|
|
|
|
|||||||
Long-term loan from related parties |
||||||||||||
Yingzhi (Lisa) Tang (a) |
||||||||||||
Yan Jiang (b) |
||||||||||||
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
(a) | In July 2018, the Company entered into a forty-month loan agreement with Yingzhi (Lisa) Tang, for a principal amount of US$ |
(b) | The balance as of December 31, 2019 represented a two-year loan of RMB |
29. |
Commitments and contingencies |
(a) |
Capital commitments |
(b) |
Contingencies |
30. |
Subsequent events |
31. |
Restricted net assets |